package com.pramod.validator.data

import com.pramod.validator.data.models.Question

object QualityUnitQuestions {
    
    fun getAllQuestions(): List<Question> {
        return listOf(
            // Annual Product Quality Review (APQR)
            Question("qu_apqr_1", "qu_apqr", "Is there an approved SOP defining APQR process (data collection, analysis, conclusions, actions) and timeline (due Q1 annually, approved <=60 days)?", 1),
            Question("qu_apqr_2", "qu_apqr", "Are APQRs prepared annually for every commercial product/strength/pack size marketed in prior year, including low volume?", 2),
            Question("qu_apqr_3", "qu_apqr", "Are deviation and CAPA trends analyzed (Pareto top 5 causes, closure rates >=95%, effectiveness verified) for the product review period?", 3),
            Question("qu_apqr_4", "qu_apqr", "Are stability trends (OOS/OOT, shelf-life confirmation, excursions) graphed and analyzed with impact on expiry?", 4),
            Question("qu_apqr_5", "qu_apqr", "Are yield trends reviewed (stage-wise graphs, expected vs actual, abnormalities investigated) for all batches?", 5),
            Question("qu_apqr_6", "qu_apqr", "Are complaint trends (volume/type/rate per million units) analyzed/risk-assessed with linkages to deviations/CAPA?", 6),
            Question("qu_apqr_7", "qu_apqr", "Are product-specific change controls reviewed (approved, implemented, effectiveness post-change data stable)?", 7),
            Question("qu_apqr_8", "qu_apqr", "Are OOS/OOT trends (invalidated rate <10%, lab/manufacturing root causes) included with investigation summaries?", 8),
            Question("qu_apqr_9", "qu_apqr", "Is process capability evaluated (Cpk >=1.33 critical CQAs, control charts) using statistical tools for >=12 months data?", 9),
            Question("qu_apqr_10", "qu_apqr", "Are environmental monitoring trends (viable/non-viable excursions, cleanroom classification) reviewed for product impact?", 10),
            Question("qu_apqr_11", "qu_apqr", "Are supplier quality issues (COA deviations, OOS raw materials) summarized with audit findings and qualification status?", 11),
            Question("qu_apqr_12", "qu_apqr", "Are market withdrawals, recalls, or FAR events evaluated with root causes and preventive measures?", 12),
            Question("qu_apqr_13", "qu_apqr", "Are cleaning validation trends (swab failures, MAC compliance) and cross-contamination risks assessed?", 13),
            Question("qu_apqr_14", "qu_apqr", "Are batch failures/rejects summarized (count, reasons, investigations closed) with trend vs prior years?", 14),
            Question("qu_apqr_15", "qu_apqr", "Are manufacturing process improvements recommended based on trends (e.g., yield optimization, control tightening)?", 15),
            Question("qu_apqr_16", "qu_apqr", "Are equipment/facility issues (breakdowns, calibration drifts) reviewed for product-specific impact?", 16),
            Question("qu_apqr_17", "qu_apqr", "Are regulatory commitments (FDA responses, variations) tracked to closure with status in APQR?", 17),
            Question("qu_apqr_18", "qu_apqr", "Are APQRs reviewed/approved by QA Head with signatory confirming data accuracy and conclusions?", 18),
            Question("qu_apqr_19", "qu_apqr", "Are APQR action items (enhancements, studies) tracked to closure via QMS with due dates <=12 months?", 19),
            Question("qu_apqr_20", "qu_apqr", "Are APQRs proactively referenced during PAI/routine inspections with executive summary provided?", 20),
            Question("qu_apqr_21", "qu_apqr", "Are training gaps/completion rates identified in APQR with linkage to quality events?", 21),
            Question("qu_apqr_22", "qu_apqr", "Are APQRs presented/reviewed by senior management (QMR) with decisions documented?", 22),
            Question("qu_apqr_23", "qu_apqr", "Are control charts/trending graphs used (Shewhart, Cpk plots) for yields, assays, impurities where >=12 data points?", 23),
            Question("qu_apqr_24", "qu_apqr", "Is data integrity verified for APQR source data (audit trails reviewed, raw data attached, ALCOA+ compliant)?", 24),
            Question("qu_apqr_25", "qu_apqr", "Are APQRs archived (digital/paper secure) with retention >= product discontinuation +1yr?", 25),

            // Audit Management
            Question("qu_audit_1", "qu_audit", "Is there an approved annual audit program covering internal (self-inspections), external (contractors), and supplier audits, with >=90% execution rate and risk-based prioritization?", 1),
            Question("qu_audit_2", "qu_audit", "Are internal/external auditors trained (40h initial +8h annual refresher) and qualified based on experience (>=3yr GMP), competency assessments (>=90% mock audit), and independence?", 2),
            Question("qu_audit_3", "qu_audit", "Are annual internal audit schedules risk-based (FMEA RPN>50, prior findings, new processes) with documented rationale and approved by Quality Head?", 3),
            Question("qu_audit_4", "qu_audit", "Are audit checklists developed/updated using regulatory guidelines (FDA Forms 483, Eudralex Vol 4, ICH Q10) covering all GMP areas with version control?", 4),
            Question("qu_audit_5", "qu_audit", "Are audit observations categorized (critical/major/minor) using objective criteria (patient risk, GMP violation type) with definitions/examples in SOP?", 5),
            Question("qu_audit_6", "qu_audit", "Are draft audit reports issued to auditees within defined timelines (critical <=7 days, routine <=14 days) with final QA sign-off <=30 days?", 6),
            Question("qu_audit_7", "qu_audit", "Are auditees required to respond (root cause, CAPA plan, timelines) within defined timeframe (critical <=14 days, major <=30 days, minor <=45 days)?", 7),
            Question("qu_audit_8", "qu_audit", "Are audit responses evaluated for completeness/adequacy by independent QA reviewer using standardized checklist before acceptance?", 8),
            Question("qu_audit_9", "qu_audit", "Are CAPAs from audits created/tracked to closure (evidence, effectiveness check) via QMS, with <=5% overdue at any time?", 9),
            Question("qu_audit_10", "qu_audit", "Are repeat/recurring findings trended quarterly (by area, product, supplier) with systemic CAPA escalation?", 10),
            Question("qu_audit_11", "qu_audit", "Are high-risk/critical findings escalated to senior management (Quality Committee) within 48h with interim controls required?", 11),
            Question("qu_audit_12", "qu_audit", "Are follow-up audits scheduled/executed for critical findings (<=6 months post-CAPA due) to verify effectiveness?", 12),
            Question("qu_audit_13", "qu_audit", "Are suppliers audited based on risk classification (critical API annual, low-risk 3yr) with qualification status matrix updated post-audit?", 13),
            Question("qu_audit_14", "qu_audit", "Are audit trails/system logs reviewed during Computerized System Validation (CSV) audits per Part 11/Annex 11 requirements?", 14),
            Question("qu_audit_15", "qu_audit", "Are audit reports controlled (unique IDs, versions) and archived securely (fireproof, 5yr retention) with retrievability <30min?", 15),
            Question("qu_audit_16", "qu_audit", "Are external audit findings (FDA 483s, MHRA GLP, customer audits) integrated into internal audit planning/next schedule?", 16),
            Question("qu_audit_17", "qu_audit", "Are corporate audits harmonized with site audits (shared checklists, findings consolidated) to avoid duplication?", 17),
            Question("qu_audit_18", "qu_audit", "Are third-party auditors pre-qualified (credentials, references, site audit) before use, with performance monitored via post-audit reviews?", 18),
            Question("qu_audit_19", "qu_audit", "Are auditors independent of audited departments (no line reporting <2 levels), with conflicts declared/resolved pre-assignment?", 19),
            Question("qu_audit_20", "qu_audit", "Are mock regulatory inspections performed >=2x/year (full site, unannounced) with findings trended and preparedness score >=90%?", 20),
            Question("qu_audit_21", "qu_audit", "Are audit KPIs tracked monthly (schedule adherence >=95%, CAPA closure <=90 days, recurrence <5%) via dashboard?", 21),
            Question("qu_audit_22", "qu_audit", "Are audit summaries (key findings, CAPA status, trends) included in quarterly management reviews with actions assigned?", 22),
            Question("qu_audit_23", "qu_audit", "Are unannounced audits included in program for suppliers/high-risk areas (>=20% supplier audits unannounced)?", 23),
            Question("qu_audit_24", "qu_audit", "Are audit tools (checklists, templates, scoring matrices) version controlled, approved by QA, and training provided on updates?", 24),
            Question("qu_audit_25", "qu_audit", "Are auditees trained annually on audit preparedness (document readiness, response SOPs, mock drills) with >=90% participation?", 25),

            // CAPA (1.3)
            Question("qu_capa_1", "qu_capa", "Does the CAPA SOP explicitly reference ICH Q10 Pharmaceutical Quality System, defining CAPA as resulting from deviations/complaints/audits, with effectiveness evaluation and risk-based prioritization?", 1),
            Question("qu_capa_2", "qu_capa", "Are CAPAs systematically linked to source events (deviations, complaints, audit findings, OOS investigations) with bidirectional cross-references maintained in the QMS for full traceability?", 2),
            Question("qu_capa_3", "qu_capa", "Does every CAPA record clearly trace recommended actions back to specific root cause(s) identified in the originating deviation/investigation, with explicit cause-action mapping table?", 3),
            Question("qu_capa_4", "qu_capa", "Are CAPA actions documented as specific, measurable, achievable, relevant, and time-bound (SMART), with predefined success metrics (e.g., reduce OOS rate from 2.5% to <0.5% by Q2 2026)?", 4),
            Question("qu_capa_5", "qu_capa", "For long-term CAPAs (>90 days implementation), are interim risk controls (e.g., 100% inspection, additional EM points) defined, implemented immediately, and monitored until full resolution?", 5),
            Question("qu_capa_6", "qu_capa", "Are CAPAs categorized as effectiveness-impacting (process improvement, risk reduction) versus compliance-impacting (regulatory findings, SOP gaps), with different effectiveness criteria per type?", 6),
            Question("qu_capa_7", "qu_capa", "Are overdue CAPAs (e.g., >30 days past due date) automatically escalated to department head and Quality Management (email/workflow), with aging report reviewed weekly?", 7),
            Question("qu_capa_8", "qu_capa", "Are CAPAs closed only after documented evidence of full implementation (attachments, verification signatures) and effectiveness check completion, not based on owner self-certification alone?", 8),
            Question("qu_capa_9", "qu_capa", "Are CAPA effectiveness checks performed by qualified personnel independent of action implementation (e.g., QA audits second analyst verification), with predefined KPIs met?", 9),
            Question("qu_capa_10", "qu_capa", "Are CAPA target dates established using risk-based rationale (critical <=60 days, major <=90 days, minor <=180 days), documented in the record, and reviewed during monthly CAPA meetings?", 10),
            Question("qu_capa_11", "qu_capa", "Are CAPAs trended quarterly (by root cause type, department, product) to identify recurrence patterns, with Pareto charts and systemic actions in management review?", 11),
            Question("qu_capa_12", "qu_capa", "Are closed CAPAs reopened if effectiveness checks fail (e.g., same deviation recurs within 6 months) or new related issues emerge, per defined criteria in CAPA SOP?", 12),
            Question("qu_capa_13", "qu_capa", "Are CAPA outcomes, effectiveness rates (>=90% success), and trends for each product included in Annual Product Review (APR/APQR) with management actions documented?", 13),
            Question("qu_capa_14", "qu_capa", "Is CAPA closure quality (evidence completeness, effectiveness metrics) specifically reviewed during internal audits/self-inspections, with findings trended and follow-up required?", 14),
            Question("qu_capa_15", "qu_capa", "When procedural gaps are identified, does the CAPA include specific SOP revisions with stakeholder review, training rollout, and effectiveness measured by compliance audits (>=95%)?", 15),
            Question("qu_capa_16", "qu_capa", "Are training needs from CAPAs assessed via gap analysis, with effectiveness verified by post-training assessments (>=90% pass rate) or KPI improvement within 90 days?", 16),
            Question("qu_capa_17", "qu_capa", "Are equipment-related CAPAs (preventive maintenance gaps, calibration drift) integrated with engineering change control and work order systems, with requalification before closure?", 17),
            Question("qu_capa_18", "qu_capa", "Are CAPAs for high-risk issues (FMEA RPN>100) explicitly linked to Quality Risk Management plans, with residual risk recalculated post-implementation?", 18),
            Question("qu_capa_19", "qu_capa", "Are cross-functional teams assigned defined roles/responsibilities for CAPA action closure (e.g., production verifies, QA audits, engineering qualifies), with sign-offs required?", 19),
            Question("qu_capa_20", "qu_capa", "Are CAPAs for product complaints integrated with pharmacovigilance when patient safety signals exist, with PV assessment documented before closure?", 20),
            Question("qu_capa_21", "qu_capa", "Are market-impacting CAPAs (recalls, stability failure, sterility issue) evaluated for regulatory reporting requirements (e.g., Field Alert <=15 days, variation filing) with timelines met?", 21),
            Question("qu_capa_22", "qu_capa", "Are CAPA files safeguarded from unauthorized edits via 21 CFR Part 11 electronic signatures, role-based access, and immutable audit trails showing all changes?", 22),
            Question("qu_capa_23", "qu_capa", "Are CAPAs identifying systemic issues (recurring across products/sites, >=3 similar in 6 months) escalated to corporate Quality governance committees with executive review?", 23),
            Question("qu_capa_24", "qu_capa", "Where applicable (OOS complaints), are CAPAs supported by witness samples/retain analysis with documented storage conditions and chain-of-custody maintained?", 24),
            Question("qu_capa_25", "qu_capa", "Does the CAPA management system (QMS/LIMS) support full audit trails (creation to closure, all approvals, evidence uploads) compliant with data integrity ALCOA+ principles?", 25),

            // Change Control
            Question("qu_change_control_1", "qu_change_control", "Is there an approved SOP defining full change control lifecycle: initiation (form submission), impact assessment (QRM), approval (multi-level), implementation (work orders), closure (verification)?", 1),
            Question("qu_change_control_2", "qu_change_control", "Are changes categorized as minor (no validation), major (validation required), critical (regulatory filing) with clear definitions, examples, and decision matrix in SOP?", 2),
            Question("qu_change_control_3", "qu_change_control", "Are all GxP changes initiated via formal change control record prior to implementation, with 100% compliance verified by retrospective audits?", 3),
            Question("qu_change_control_4", "qu_change_control", "Are cross-functional evaluations (QA, Production, QC, Engineering, RA) documented for each change via sign-off matrix or meeting minutes?", 4),
            Question("qu_change_control_5", "qu_change_control", "Is Quality Risk Management (FMEA/PHA, RPN calculated) included for every change to evaluate product/process impact pre-approval?", 5),
            Question("qu_change_control_6", "qu_change_control", "Is regulatory filing impact (CBE, PAS, annual report) assessed/documented by RA for changes affecting NDA/ANDA specs/process, with submission tracked?", 6),
            Question("qu_change_control_7", "qu_change_control", "Are validation/qualification requirements (IQ/OQ/PQ, cleaning verification, stability) determined/documented as part of change control, executed pre-closure?", 7),
            Question("qu_change_control_8", "qu_change_control", "Are changes linked to relevant CAPAs/deviations/OOS with cross-references when originating from quality events?", 8),
            Question("qu_change_control_9", "qu_change_control", "Are temporary changes (<=90 days trials) controlled via separate procedure with risk assessment, monitoring plan, and retrospective full review?", 9),
            Question("qu_change_control_10", "qu_change_control", "Are changes impacting product/method specs reviewed/approved by Quality and Regulatory before implementation?", 10),
            Question("qu_change_control_11", "qu_change_control", "Are equipment/facility changes evaluated for re-qualification status (partial/full IQ/OQ/PQ) based on risk assessment?", 11),
            Question("qu_change_control_12", "qu_change_control", "Are software/system changes evaluated under Computerized System Validation (CSV) requirements (GAMP 5 risk category, testing plan)?", 12),
            Question("qu_change_control_13", "qu_change_control", "Are supplier-related changes (API/excipient site switch) assessed for material impact via comparability protocol and stability?", 13),
            Question("qu_change_control_14", "qu_change_control", "Are effectiveness checks defined/executed for major/critical changes (KPIs met, post-change data stable 6 months) before closure?", 14),
            Question("qu_change_control_15", "qu_change_control", "Are change control timelines risk-based/monitored (critical <=60 days, major <=90 days) via dashboard with overdue escalations?", 15),
            Question("qu_change_control_16", "qu_change_control", "Are change approvals documented with individual justifications (risk acceptance, mitigations) from each approver?", 16),
            Question("qu_change_control_17", "qu_change_control", "Are emergency changes (unplanned urgent fixes) controlled retrospectively (within 7 days full review/risk assessment/approval) per SOP?", 17),
            Question("qu_change_control_18", "qu_change_control", "Are changes to cleaning processes evaluated for cross-contamination risk (MAC/PDE recalculation, swab verification)?", 18),
            Question("qu_change_control_19", "qu_change_control", "Are change history records complete/traceable (what/who/when/rationale) for >=5 years, audit trail compliant?", 19),
            Question("qu_change_control_20", "qu_change_control", "Are training requirements (affected personnel) defined/completed (>=95% trained) before change implementation?", 20),
            Question("qu_change_control_21", "qu_change_control", "Are changes to batch records (MPR/BMR templates) reviewed/verified by QA/production before use in production?", 21),
            Question("qu_change_control_22", "qu_change_control", "Are packaging/artwork changes tracked/verified (mock-ups, barcode validation, supplier proofs) pre-implementation?", 22),
            Question("qu_change_control_23", "qu_change_control", "Are changes evaluated for impact on ongoing/in-process batches, with hold/quarantine if required?", 23),
            Question("qu_change_control_24", "qu_change_control", "Are post-implementation reviews performed/documented (6 months data, KPIs stable) for major changes before closure?", 24),
            Question("qu_change_control_25", "qu_change_control", "Are change control metrics (cycle time, overdue %, CAPA linkage) reviewed quarterly in management review with improvement actions?", 25),

            // Complaint Management
            Question("qu_complaint_mgmt_1", "qu_complaint_mgmt", "Is there an approved SOP defining complaint receipt (phone/email/log), logging, triage (critical/major/minor per criteria), investigation (scope/timeline), and closure (response/CAPA) for all product/service complaints?", 1),
            Question("qu_complaint_mgmt_2", "qu_complaint_mgmt", "Are complaints categorized as critical (patient harm potential), major (quality defect, no harm), or minor (cosmetic/labeling) with clear, documented definitions, examples, and initial triage within 24h?", 2),
            Question("qu_complaint_mgmt_3", "qu_complaint_mgmt", "Are complaint investigations initiated within defined timelines (critical <=24h, major <=3 days, minor <=7 days) with aging reports tracked weekly and escalations for delays?", 3),
            Question("qu_complaint_mgmt_4", "qu_complaint_mgmt", "Are complaints indicating adverse drug events (ADEs) or safety signals escalated to pharmacovigilance/global safety without delay (<=24h) with PV case# cross-referenced in complaint file?", 4),
            Question("qu_complaint_mgmt_5", "qu_complaint_mgmt", "Is market history/trending (prior complaints, batch performance, OOS rates for same lot/supplier) reviewed during every complaint assessment and documented in investigation scope?", 5),
            Question("qu_complaint_mgmt_6", "qu_complaint_mgmt", "Are reserve/retain samples (same lot, same packaging) evaluated (visual/microbial/analytical) as part of every quality complaint investigation, with side-by-side comparison to complainant sample?", 6),
            Question("qu_complaint_mgmt_7", "qu_complaint_mgmt", "Are manufacturing (BMR/BPR), laboratory (OOS history), and QC records reviewed for every market complaint, with specific cross-references to batch documentation?", 7),
            Question("qu_complaint_mgmt_8", "qu_complaint_mgmt", "Are complaint investigation conclusions scientifically justified (data, testing, stats) and free from unsubstantiated assumptions (e.g., customer error without evidence)?", 8),
            Question("qu_complaint_mgmt_9", "qu_complaint_mgmt", "Is distribution data (ship dates, quantities, customers, storage/transit conditions) reviewed to identify and quarantine potentially affected lots within 48h?", 9),
            Question("qu_complaint_mgmt_10", "qu_complaint_mgmt", "Are recurring complaints (>=3 same type/product in 6 months) automatically escalated to systemic investigations with FMEA or root cause trending beyond single lot?", 10),
            Question("qu_complaint_mgmt_11", "qu_complaint_mgmt", "Are packaging integrity complaints (leaks, broken seals) analyzed with statistical sampling (AQL 1.0%) of retains and trend analysis by supplier/lot?", 11),
            Question("qu_complaint_mgmt_12", "qu_complaint_mgmt", "Are complaint files complete with complainant communication logs, evidence (photos, test data), investigation report, and CAPA status, retained >=1yr post-expiry?", 12),
            Question("qu_complaint_mgmt_13", "qu_complaint_mgmt", "Are complaint conclusions supported by laboratory re-testing data (complainant + retain samples) when chemical/microbial analysis is indicated, with full raw data attached?", 13),
            Question("qu_complaint_mgmt_14", "qu_complaint_mgmt", "Are products returned with complaints quarantined immediately upon receipt, visually/microbiologically examined, and dispositioned by QA within 7 days?", 14),
            Question("qu_complaint_mgmt_15", "qu_complaint_mgmt", "Are complaint files in electronic systems protected with audit trails (21 CFR Part 11/Annex 11) recording all entries, edits, and approvals with no deletions?", 15),
            Question("qu_complaint_mgmt_16", "qu_complaint_mgmt", "Are closed complaint investigations reopened when new information emerges (e.g., related recall, pattern identification) within SOP criteria (<=1yr post-closure)?", 16),
            Question("qu_complaint_mgmt_17", "qu_complaint_mgmt", "Are counterfeit or tampering complaints escalated to regulatory agencies (FDA MedWatch, EMA) and law enforcement within 24h, with samples preserved for forensic analysis?", 17),
            Question("qu_complaint_mgmt_18", "qu_complaint_mgmt", "Are distribution-related complaints (temp excursions, damage) evaluated via carrier data loggers, route mapping, and cold chain validation records?", 18),
            Question("qu_complaint_mgmt_19", "qu_complaint_mgmt", "Are all customer communications (acknowledgment <=48h, final response <=30 days) documented, pre-approved by QA, and retained verbatim in complaint file?", 19),
            Question("qu_complaint_mgmt_20", "qu_complaint_mgmt", "Are timelines for complaint closure risk-based (critical <=15 days, major <=30 days, minor <=60 days) and monitored via aging dashboard with escalations?", 20),
            Question("qu_complaint_mgmt_21", "qu_complaint_mgmt", "Is complaint data (volume, types, trends, closure rates) integrated into Annual Product Quality Review (APQR) with root cause analysis and CAPA effectiveness?", 21),
            Question("qu_complaint_mgmt_22", "qu_complaint_mgmt", "Is annual training provided to all complaint handlers (receipt, triage, investigation) with competency assessment (>=90% test score) and refresher on SOP changes?", 22),
            Question("qu_complaint_mgmt_23", "qu_complaint_mgmt", "Are complaint investigations traced to CAPA, change control, or risk assessments when root causes indicate systemic issues, with cross-references in all records?", 23),
            Question("qu_complaint_mgmt_24", "qu_complaint_mgmt", "Are complaint trending reports (monthly by product/type/source, Pareto top 5) reviewed by senior management (Quality Committee) with action items assigned?", 24),
            Question("qu_complaint_mgmt_25", "qu_complaint_mgmt", "Are complaint investigations extended to sister plants/manufacturing sites using same material/process, with shared findings and coordinated CAPA?", 25),

            // Computer System Validation
            Question("qu_csv_1", "qu_csv", "Is there an approved CSV SOP aligned with GAMP 5 (risk-based lifecycle), FDA 21 CFR Part 11 (records/signatures), and Annex 11 (CSV principles), covering all GxP systems?", 1),
            Question("qu_csv_2", "qu_csv", "Are computerized systems categorized by GxP impact (Category 1 configurable, 3 non-configured, 4/5 custom/infrastructure) per GAMP 5 with documented rationale?", 2),
            Question("qu_csv_3", "qu_csv", "Are User Requirements Specifications (URS) approved by stakeholders before system design/procurement, with traceability matrix to functional specs?", 3),
            Question("qu_csv_4", "qu_csv", "Are Functional (FS) and Design Specifications (DS) documented, traceable to URS via matrix, and approved before configuration/development?", 4),
            Question("qu_csv_5", "qu_csv", "Are GAMP 5 risk assessments (FMEA for data integrity, patient safety) performed for each system, classifying modules/tests pre-validation?", 5),
            Question("qu_csv_6", "qu_csv", "Are Validation Master Plans (VMP) or system Validation Plans developed with clear acceptance criteria, OQ/PQ scope based on risk?", 6),
            Question("qu_csv_7", "qu_csv", "Are IQ (installation), OQ (operational), PQ (performance) protocols approved/executed with traceability to URS/FS, deviations closed <=30 days?", 7),
            Question("qu_csv_8", "qu_csv", "Are electronic records/signatures Part 11 compliant (unique ID, audit trail, non-repudiation, validation of intent)?", 8),
            Question("qu_csv_9", "qu_csv", "Are secure audit trails enabled (user actions, timestamps, before/after values) and reviewed periodically (weekly critical, monthly routine) with exceptions investigated?", 9),
            Question("qu_csv_10", "qu_csv", "Are system updates/patches managed via change control (risk assessment, regression testing, re-qualification per GAMP)?", 10),
            Question("qu_csv_11", "qu_csv", "Are software suppliers audited/qualified (questionnaire, audit report, right-to-audit clause) before use for GxP systems?", 11),
            Question("qu_csv_12", "qu_csv", "Are data backup/restore procedures validated (full/incremental schedules, media integrity, recovery time <=4h) with quarterly tests >=99% success?", 12),
            Question("qu_csv_13", "qu_csv", "Are disaster recovery plans (BCP/DR) defined/tested annually (failover <=24h, full recovery <=72h) for critical GxP systems?", 13),
            Question("qu_csv_14", "qu_csv", "Are GxP spreadsheets validated (change control, password protection, formula lock, peer review) or prohibited with alternatives enforced?", 14),
            Question("qu_csv_15", "qu_csv", "Are system access rights role-based, reviewed semi-annually (certification by managers), with immediate revocation for role changes?", 15),
            Question("qu_csv_16", "qu_csv", "Are training records maintained for system users (initial 4h + annual refresher, competency >=90%) with matrix current >=95%?", 16),
            Question("qu_csv_17", "qu_csv", "Are system performance (uptime >=99%) and error logs reviewed monthly, with trends triggering maintenance/CAPA?", 17),
            Question("qu_csv_18", "qu_csv", "Are interfaces between GxP systems (LIMS-MES, ERP-QMS) validated for data integrity (accuracy, completeness, no loss)?", 18),
            Question("qu_csv_19", "qu_csv", "Are data archival processes validated (WORM compliance, readability 10yrs, migration tested) per retention schedules?", 19),
            Question("qu_csv_20", "qu_csv", "Are cyber-security controls (firewall, encryption, vulnerability scans) validated/tested annually for GxP systems?", 20),
            Question("qu_csv_21", "qu_csv", "Are periodic reviews performed (annual for critical, 2yr routine) assessing compliance, performance, and retirement needs?", 21),
            Question("qu_csv_22", "qu_csv", "Are system decommissioning procedures defined (data migration, archival, secure wipe) with final QA sign-off?", 22),
            Question("qu_csv_23", "qu_csv", "Are legacy systems risk-evaluated for Part 11/Annex 11 gaps, with remediation/migration plans if non-compliant?", 23),
            Question("qu_csv_24", "qu_csv", "Are vendor-supplied documentation (IQ/OQ scripts) and patches independently verified (hands-on testing) before acceptance?", 24),
            Question("qu_csv_25", "qu_csv", "Are validation documents archived securely (fireproof/digital WORM, retrievable <30min) for inspection (lifecycle +1yr)?", 25),

            // Data Integrity Governance
            Question("qu_data_integrity_1", "qu_data_integrity", "Is there a site-wide data integrity policy explicitly aligned with ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available), approved by senior management, and communicated?", 1),
            Question("qu_data_integrity_2", "qu_data_integrity", "Are roles/responsibilities for DI governance clearly defined (e.g., Data Stewards, System Owners, QA Reviewers) in the DI policy/SOP, with RACI matrix and annual training acknowledgment?", 2),
            Question("qu_data_integrity_3", "qu_data_integrity", "Are all GxP electronic systems (LIMS, QMS, ERP, MES) validated per GAMP 5/Annex 11 (URS, IQ/OQ/PQ/CSV) to ensure secure data handling, with current validation status documented?", 3),
            Question("qu_data_integrity_4", "qu_data_integrity", "Are secure, time-stamped audit trails enabled/reviewed/maintained for all GxP systems (raw data/metadata changes), with defined review frequency (e.g., weekly critical, monthly routine)?", 4),
            Question("qu_data_integrity_5", "qu_data_integrity", "Are data access controls role-based (least privilege principle), with periodic reviews (semi-annual access certification by managers) and immediate revocation for leavers?", 5),
            Question("qu_data_integrity_6", "qu_data_integrity", "Are unique user IDs/passwords (no shared accounts) assigned to each authorized GxP user, with password policies (8+ chars, 90-day expiry, no reuse of last 10) enforced?", 6),
            Question("qu_data_integrity_7", "qu_data_integrity", "Are raw data, metadata (audit trails, configs), and contextual information retained/protected (immutable format, lifecycle defined) for regulatory periods (e.g., 1yr post-expiry)?", 7),
            Question("qu_data_integrity_8", "qu_data_integrity", "Are hybrid paper-electronic systems minimized (<10% GxP records), and if used, properly controlled with certified true copies, reconciliation, and retention per DI SOP?", 8),
            Question("qu_data_integrity_9", "qu_data_integrity", "Are paper records contemporaneous (real-time entry), legible (permanent ink), and compliant with GDP (single-line corrections, no erasable ink/whiteout, dual initials)?", 9),
            Question("qu_data_integrity_10", "qu_data_integrity", "Are system clocks synchronized (NTP server, daily check +/-1min accuracy) and protected from manual changes, with drift logs reviewed monthly?", 10),
            Question("qu_data_integrity_11", "qu_data_integrity", "Are unauthorized data edits (audit trail flags) automatically tracked/investigated within 24h, with root cause and CAPA per DI incident SOP?", 11),
            Question("qu_data_integrity_12", "qu_data_integrity", "Are electronic signatures compliant with 21 CFR Part 11 (unique to signer, operationally equivalent to wet ink, intent disclosed), with non-repudiation verified?", 12),
            Question("qu_data_integrity_13", "qu_data_integrity", "Are data backups secure (encrypted, offsite), validated (frequency, format), and tested quarterly for restorability (<4h full recovery, 100% data integrity check)?", 13),
            Question("qu_data_integrity_14", "qu_data_integrity", "Are data integrity risks (e.g., manual transcription, spreadsheet errors, access abuse) explicitly included in Quality Risk Management (FMEA RPN>50) with mitigations?", 14),
            Question("qu_data_integrity_15", "qu_data_integrity", "Are all GxP personnel trained in DI principles (ALCOA+ awareness 2h annual, role-specific 4h initial), with competency assessment >=90% pass rate?", 15),
            Question("qu_data_integrity_16", "qu_data_integrity", "Is local data storage on desktops/USB/personal devices prohibited for GxP data, enforced via Group Policy/DLP, with violations tracked as DI deviations?", 16),
            Question("qu_data_integrity_17", "qu_data_integrity", "Are spreadsheet calculations used in GxP decisions validated (change-controlled, password-protected, formula integrity checks) or migrated to validated systems?", 17),
            Question("qu_data_integrity_18", "qu_data_integrity", "Are audit trail reviews performed at defined risk-based intervals (daily critical systems, weekly routine, monthly full), with exceptions investigated <=24h?", 18),
            Question("qu_data_integrity_19", "qu_data_integrity", "Are data integrity incidents (deletion, falsification, access abuse) escalated to senior management (Quality Head) within 24h, with root cause and CAPA required?", 19),
            Question("qu_data_integrity_20", "qu_data_integrity", "Is governance defined for cloud-based GxP systems (e.g., SLAs, data sovereignty, subcontracting approval) with annual third-party audits >=90% compliance?", 20),
            Question("qu_data_integrity_21", "qu_data_integrity", "Are DI breaches, audit trail exceptions, and training compliance included in annual management reviews with KPIs (e.g., DI incidents <1%, review coverage 100%)?", 21),
            Question("qu_data_integrity_22", "qu_data_integrity", "Are temporary/shared logins prohibited, with monitoring for violations (e.g., concurrent sessions) and automatic lockout after 3 failed attempts?", 22),
            Question("qu_data_integrity_23", "qu_data_integrity", "Are electronic record retention rules followed (e.g., migrate to WORM archival post-active use, readability verified 10yrs) per regulatory timelines?", 23),
            Question("qu_data_integrity_24", "qu_data_integrity", "Are atypical data trends (e.g., clustered OOS, uniform values) investigated as potential DI issues using statistical tests (Benford\'s Law, control charts)?", 24),
            Question("qu_data_integrity_25", "qu_data_integrity", "Are DI controls periodically assessed through targeted internal audits/self-inspections (annual coverage >=90% systems), with findings trended and CAPA tracked?", 25),

            // Deviations
            Question("qu_deviations_1", "qu_deviations", "Does the site have an approved Standard Operating Procedure (SOP) for deviations that defines written classification criteria for minor, major, and critical deviations (for example, including specific examples for each category)?", 1),
            Question("qu_deviations_2", "qu_deviations", "Does the site's deviation SOP provide a documented decision tree or flowchart for category assignment based on the defined classification criteria?", 2),
            Question("qu_deviations_3", "qu_deviations", "Are deviations opened in the electronic or paper system promptly (for example, initiated within 24 hours of detection and documented contemporaneously with date, time, and reporter identity)?", 3),
            Question("qu_deviations_4", "qu_deviations", "Are all unplanned events on the shop floor (including near-misses, temporary fixes, and undocumented workarounds) consistently captured as deviations per SOP, rather than informal logbook notes only?", 4),
            Question("qu_deviations_5", "qu_deviations", "Are deviations occurring before marketing authorization (e.g., process validation, exhibit batches) assessed and documented for potential regulatory filing impact (e.g., need for supplement/variation)?", 5),
            Question("qu_deviations_6", "qu_deviations", "Are deviations discovered retrospectively after batch release (e.g., documentation gaps, late lab result issues) managed through formal deviation records that include recall/market complaint risk assessment and regulatory notification evaluation?", 6),
            Question("qu_deviations_7", "qu_deviations", "Does QA review and approve deviation classification to ensure events are not downgraded from major/critical to minor without documented, science- and risk-based justification?", 7),
            Question("qu_deviations_8", "qu_deviations", "Before closure, does QA verify that the deviation narrative is factually complete (who/what/when/where), objective, and internally consistent with supporting evidence (logs, chromatograms, pictures)?", 8),
            Question("qu_deviations_9", "qu_deviations", "For critical and major deviations, is Quality Assurance (QA) presence or oversight documented during on-floor verification steps (for example, production line checks, representative sample pulls, and equipment inspections)?", 9),
            Question("qu_deviations_10", "qu_deviations", "Are deviation records (electronic or paper) protected from unauthorized edits or deletion through role-based access control, audit trails, or controlled corrections per data integrity guidance?", 10),
            Question("qu_deviations_11", "qu_deviations", "Does the deviation system (forms, LIMS/QMS modules) comply with ALCOA+ data integrity principles (attributable, legible, contemporaneous, original, accurate, plus complete, consistent, enduring, and available)?", 11),
            Question("qu_deviations_12", "qu_deviations", "Are target timelines for deviation investigation and closure defined by risk category (e.g., minor <=30 days, major <=45 days, critical <=30 days) and routinely met, with overdue cases trended?", 12),
            Question("qu_deviations_13", "qu_deviations", "Are any extensions to deviation closure timelines documented with scientific and/or business justification, approved by QA, and limited in number (e.g., maximum 1 extension per record)?", 13),
            Question("qu_deviations_14", "qu_deviations", "Are recurring minor deviations automatically or manually trended (e.g., >=3 similar events in 3 months) and escalated to major/systemic investigations with CAPA, as defined in the deviation SOP?", 14),
            Question("qu_deviations_15", "qu_deviations", "Are deviation trends periodically reviewed (at least quarterly) by product, equipment, line, utility, and personnel, with documented meeting minutes and defined follow-up actions?", 15),
            Question("qu_deviations_16", "qu_deviations", "Are all deviations for each product included and evaluated in the Annual Product Review/Product Quality Review (APR/APQR), with summaries of frequency, root causes, and CAPA effectiveness?", 16),
            Question("qu_deviations_17", "qu_deviations", "Does every deviation record include a documented batch impact assessment (including all potentially affected batches) with scientific rationale (e.g., worst-case assumptions, reference to validation data)?", 17),
            Question("qu_deviations_18", "qu_deviations", "When required by risk, are OOS/OOT or process deviations extended to related or potentially affected batches, lines, or markets, and documented in the investigation scope?", 18),
            Question("qu_deviations_19", "qu_deviations", "Are root causes determined using structured tools (e.g., 5-Why, fishbone, FMEA), and re-evaluated if investigations are inconclusive or if similar deviations recur within a defined period?", 19),
            Question("qu_deviations_20", "qu_deviations", "For deviations impacting multiple systems (e.g., utilities, QC, IT, manufacturing), are cross-functional investigation teams formed and documented, with clear roles and agreed conclusions?", 20),
            Question("qu_deviations_21", "qu_deviations", "Are deviations linked, as appropriate, to CAPA, change control records, risk assessments, and training actions (e.g., SOP revision, retraining for operator-related causes), with cross-references in each system?", 21),
            Question("qu_deviations_22", "qu_deviations", "Are deviations routinely opened for excursions in environmental monitoring, HVAC, water systems, gases, or other utilities when limits are breached, with impact assessment on product and stability?", 22),
            Question("qu_deviations_23", "qu_deviations", "Whenever interlocks, alarms, or other critical controls are temporarily bypassed or overridden, is a deviation opened in advance or immediately, with documented risk assessment and QA approval?", 23),
            Question("qu_deviations_24", "qu_deviations", "For deviations attributed to human error, is a specific evaluation performed to determine if training gaps exist, with documented retraining or qualification where needed?", 24),
            Question("qu_deviations_25", "qu_deviations", "When deviations lead to systemic remediation (e.g., CAPA, process change), are effectiveness checks (KPIs, follow-up audits, or post-implementation monitoring) pre-defined, executed by due date, and documented in the deviation/CAPA record?", 25),

            // Product Disposition (Release/Rejection)
            Question("qu_disposition_1", "qu_disposition", "Is there a clear SOP defining batch disposition steps (production review -> QC review -> QA final release/quarantine) with timelines (<=5 days post-completion)?", 1),
            Question("qu_disposition_2", "qu_disposition", "Are QA reviewers independent of production (no dual hats, separate reporting line to Quality Head) per organizational chart?", 2),
            Question("qu_disposition_3", "qu_disposition", "Are batch production records (BPR/MPR) reviewed 100% for completeness/GMP compliance (dates, weights, initials, yields +/-5%) before release?", 3),
            Question("qu_disposition_4", "qu_disposition", "Are QC test results reviewed for accuracy/compliance with specs (raw data, calculations verified, standards calibrated)?", 4),
            Question("qu_disposition_5", "qu_disposition", "Are all deviations, OOS investigations (closed with RCA), and changes linked to the batch reviewed/approved prior to release?", 5),
            Question("qu_disposition_6", "qu_disposition", "Are out-of-trend (OOT) results evaluated (statistical significance, trend investigation) even if within spec?", 6),
            Question("qu_disposition_7", "qu_disposition", "Are stability study commitments (pulls completed, data on schedule) reviewed before release for shelf-life batches?", 7),
            Question("qu_disposition_8", "qu_disposition", "Are in-process controls (IPC weights, pH, uniformity) verified against limits with justifications for excursions?", 8),
            Question("qu_disposition_9", "qu_disposition", "Are electronic batch records (eBMR) validated (Part 11 audit trails, signatures) and reviewed with exception highlighting?", 9),
            Question("qu_disposition_10", "qu_disposition", "Are standardized QA review checklists used consistently (100% batches, signed sections) covering 211.188 requirements?", 10),
            Question("qu_disposition_11", "qu_disposition", "Are rejected batches documented with justification (OOS, deviation impact), quarantine status, and disposition plan?", 11),
            Question("qu_disposition_12", "qu_disposition", "Is segregation between released and quarantined materials ensured (physical ERP status, double checks) with zero mix-ups?", 12),
            Question("qu_disposition_13", "qu_disposition", "Are line clearance records (previous batch removal, label verification) reviewed for packaging batches?", 13),
            Question("qu_disposition_14", "qu_disposition", "Are environmental monitoring (Grade A viable <1 CFU) and utility (WFI TOC <500ppb) excursion records examined for impact?", 14),
            Question("qu_disposition_15", "qu_disposition", "Are retain sample quantities verified sufficient (3x monograph + stability) and properly stored per SOP?", 15),
            Question("qu_disposition_16", "qu_disposition", "Are assigned expiry/retest periods verified against approved stability data/label claim before release?", 16),
            Question("qu_disposition_17", "qu_disposition", "Are open/recent market complaints reviewed for potential impact on current batch (lot similarity)?", 17),
            Question("qu_disposition_18", "qu_disposition", "Are CQAs (assay >=98%, impurities <0.5%, dissolution >=80%) verified with trending (Cpk>=1.33)?", 18),
            Question("qu_disposition_19", "qu_disposition", "Is sampling traceability verified (plan followed, chain-of-custody, composite/homogeneity)?", 19),
            Question("qu_disposition_20", "qu_disposition", "Are batch disposition timelines monitored (median <=3 days post-QC results) with overdue escalations?", 20),
            Question("qu_disposition_21", "qu_disposition", "Are batch disposition decisions documented with electronic audit trail (Part 11 signatures, rationale attached)?", 21),
            Question("qu_disposition_22", "qu_disposition", "Are rework/reprocessing steps (protocol approved, yields reconciled, QC retest) reviewed/approved before final release?", 22),
            Question("qu_disposition_23", "qu_disposition", "Are printed packaging components verified for correctness (lot#, expiry, barcode scan, 100% check)?", 23),
            Question("qu_disposition_24", "qu_disposition", "Are trends in batch failures/rejects (Pareto by cause, rate <1%) reviewed quarterly?", 24),
            Question("qu_disposition_25", "qu_disposition", "Is batch disposition summary (release rates >=99%, trends) included in management review discussions?", 25),

            // Document Management
            Question("qu_document_mgmt_1", "qu_document_mgmt", "Does an approved SOP comprehensively cover document creation (template approval), revision (change control workflow), approval (multi-level sign-off), issuance (controlled copies), and archiving (retention schedule) for all GxP records?", 1),
            Question("qu_document_mgmt_2", "qu_document_mgmt", "Are document templates (SOPs, batch records, forms) standardized across the site using a master template library maintained by QA, with mandatory fields, headers/footers, and revision blocks?", 2),
            Question("qu_document_mgmt_3", "qu_document_mgmt", "Are revisions controlled via unique version numbers (e.g., SOP-001 Rev 5.1), with complete change history tables documenting what changed, rationale, and approver signatures for every update?", 3),
            Question("qu_document_mgmt_4", "qu_document_mgmt", "Are obsolete documents removed from point-of-use locations (workstations, shop floor binders) within 24h of supersession, verified by post-withdrawal audits, with physical destruction witnessed?", 4),
            Question("qu_document_mgmt_5", "qu_document_mgmt", "Are electronic documents protected from unauthorized modification via role-based access controls, electronic signatures (21 CFR Part 11/Annex 11 compliant), and audit trails recording all views/edits?", 5),
            Question("qu_document_mgmt_6", "qu_document_mgmt", "Do all controlled document copies (paper/electronic) bear unique identifiers (e.g., DOC-SOP-001-Rev5-CopyA001) or visible version control numbers, with uncontrolled status watermarked where applicable?", 6),
            Question("qu_document_mgmt_7", "qu_document_mgmt", "Are metadata fields (author, reviewer(s), approver(s), effective date, next review date) 100% complete, accurate, and uneditable post-approval for all controlled documents?", 7),
            Question("qu_document_mgmt_8", "qu_document_mgmt", "Are periodic reviews defined (e.g., SOPs every 3 years) and executed on schedule, with evidence of review (change/no change decision, signature) in the document record?", 8),
            Question("qu_document_mgmt_9", "qu_document_mgmt", "Are operational forms (deviation, OOS, cleaning checklists) controlled, uniquely numbered, and traceable to master document templates, with local copies prohibited?", 9),
            Question("qu_document_mgmt_10", "qu_document_mgmt", "Are logbooks (equipment, batch, cleaning) pre-numbered, bound (non-erasable), issued by QA with unique IDs, and reconciled for completeness upon return?", 10),
            Question("qu_document_mgmt_11", "qu_document_mgmt", "Are handwritten corrections performed per GDP (single black line strikeout, legible original visible, immediate justification, maker/verifier initials + date, no white-out/overwriting)?", 11),
            Question("qu_document_mgmt_12", "qu_document_mgmt", "Upon document revision, are affected personnel retrained (documented attendance, competency assessment >=90%) with training matrix updated before effective date?", 12),
            Question("qu_document_mgmt_13", "qu_document_mgmt", "Are interim SOPs, work instructions, or memos formally controlled (unique number, limited duration <=90 days, QA approval, distribution list, destruction post-supersession)?", 13),
            Question("qu_document_mgmt_14", "qu_document_mgmt", "Is the archive room environmentally controlled (15-25 degreesC, 40-60%RH, fireproof, secure access) with continuous monitoring, quarterly mapping, and alarm response verified?", 14),
            Question("qu_document_mgmt_15", "qu_document_mgmt", "Are retention timelines defined per regulation (e.g., batch records 1yr post-expiry, complaints 5yrs, stability 10yrs) and consistently applied with automated purge alerts?", 15),
            Question("qu_document_mgmt_16", "qu_document_mgmt", "Are electronic document management systems (eQMS, LIMS) validated per GAMP 5/Annex 11 (URS, IQ/OQ/PQ, CSV), with change control and periodic review executed?", 16),
            Question("qu_document_mgmt_17", "qu_document_mgmt", "Are executed batch records protected from damage/fading/loss via fireproof storage, microfilming/digital archiving (legible 10yrs), and duplicate backups tested annually?", 17),
            Question("qu_document_mgmt_18", "qu_document_mgmt", "Are controlled forms used consistently 100%, with local photocopies prohibited and detected via audits (zero tolerance, training reinforcement)?", 18),
            Question("qu_document_mgmt_19", "qu_document_mgmt", "Are critical documents (SOPs, MPRs) available at point-of-use (QR codes, tablets, laminated binders) with version verification before operations start?", 19),
            Question("qu_document_mgmt_20", "qu_document_mgmt", "Are deviations from documentation procedures (e.g., missing signatures, wrong version) captured as formal deviations with investigation and CAPA?", 20),
            Question("qu_document_mgmt_21", "qu_document_mgmt", "Are multilingual documents (local language versions) verified for consistency via back-translation or bilingual review, with identical critical content/limits as English master?", 21),
            Question("qu_document_mgmt_22", "qu_document_mgmt", "Are scanned documents (legacy paper records) legible (300dpi min, no shadows), complete (full pages, signatures visible), and validated for OCR accuracy >=99% where searchable?", 22),
            Question("qu_document_mgmt_23", "qu_document_mgmt", "Are external standards/guidelines/compendia (USP, PhEur, ICH) tracked for updates via subscription alerts, with impact assessments and internal document revisions completed <=60 days?", 23),
            Question("qu_document_mgmt_24", "qu_document_mgmt", "Are secure backups maintained for electronic documents (daily incremental, weekly full, offsite/cloud, encrypted), with quarterly restore tests confirming 100% recovery <4h?", 24),
            Question("qu_document_mgmt_25", "qu_document_mgmt", "Are document destruction activities (obsolete SOPs, expired retains) logged with QA approval, witnessed execution (shredding/weighing), and certificates retained per SOP?", 25),

            // Field Alert Reports
            Question("qu_field_alerts_1", "qu_field_alerts", "Is there an approved FAR SOP explicitly aligned with 21 CFR 314.81(b)(1), defining submission process (Form FDA 3331a, 3 working days), responsible parties, and escalation?", 1),
            Question("qu_field_alerts_2", "qu_field_alerts", "Are potential FAR triggers clearly defined in SOP (OOS distributed batches, contamination, mix-ups, sterility failures, labeling errors, deterioration) with decision tree/matrix?", 2),
            Question("qu_field_alerts_3", "qu_field_alerts", "Are FAR assessments initiated within the 3-working-day reporting window upon information receipt (e.g., OOS confirmation, complaint), with log timestamp <=72h?", 3),
            Question("qu_field_alerts_4", "qu_field_alerts", "Are responsible FAR coordinators (RA/QA leads) clearly assigned by site/NDA with contact lists, backup coverage, and annual training completion >=100%?", 4),
            Question("qu_field_alerts_5", "qu_field_alerts", "Are all quality complaints reviewed for FAR relevance (e.g., potency failure, foreign matter) during triage, with documented FAR yes/no decision <=24h?", 5),
            Question("qu_field_alerts_6", "qu_field_alerts", "Are stability OOS/OOT failures (distributed shelf-life batches) evaluated for FAR impact, including market withdrawal risk, within 3 days?", 6),
            Question("qu_field_alerts_7", "qu_field_alerts", "Are batch discrepancies (yield variance >5%, potency <95%) assessed for market risk requiring FAR, with retain testing and distribution trace completed?", 7),
            Question("qu_field_alerts_8", "qu_field_alerts", "Are distributed batch OOS/OOT lab results assessed for FAR triggers unless scientifically invalidated (lab error confirmed) within 3 working days?", 8),
            Question("qu_field_alerts_9", "qu_field_alerts", "Are manufacturing deviations (aseptic breach, equipment failure) evaluated for FAR implications on distributed product quality/safety?", 9),
            Question("qu_field_alerts_10", "qu_field_alerts", "Are critical packaging failures (seal integrity loss, tampering evidence) included in FAR evaluation for distributed lots, with visual/physical testing?", 10),
            Question("qu_field_alerts_11", "qu_field_alerts", "Is documentation supporting FAR no submission or submit decisions retained (risk assessment, retain analysis, distribution data) for >=5 years?", 11),
            Question("qu_field_alerts_12", "qu_field_alerts", "Are retain samples examined (visual, assay, sterility where applicable) for all FAR assessments, with results attached to decision record?", 12),
            Question("qu_field_alerts_13", "qu_field_alerts", "Are product quality complaints (color change, tablet breakage) systematically reviewed against FAR criteria (spec failure, contamination) during investigation?", 13),
            Question("qu_field_alerts_14", "qu_field_alerts", "Are FARs communicated internally to corporate RA and externally to FDA district office promptly (initial <=3 days, follow-up <=15 days) via Form FDA 3331a?", 14),
            Question("qu_field_alerts_15", "qu_field_alerts", "Are cross-functional teams (QA, RA, production, QC) involved in FAR assessments for complex triggers (sterility, systemic deviations)?", 15),
            Question("qu_field_alerts_16", "qu_field_alerts", "Are FARs trended quarterly (by trigger type, product, site) to identify systemic issues, with Pareto analysis in Quality Management Review?", 16),
            Question("qu_field_alerts_17", "qu_field_alerts", "Is market withdrawal/recall risk evaluated explicitly in every FAR assessment, with decision documented (e.g., FAR + recall evaluation)?", 17),
            Question("qu_field_alerts_18", "qu_field_alerts", "Are FAR-related CAPAs (root cause from investigation) created/tracked to closure, with effectiveness verification <=6 months?", 18),
            Question("qu_field_alerts_19", "qu_field_alerts", "Are FAR submit/no-submit decisions justified with documented risk assessments (patient safety, product quality impact, distribution scope)?", 19),
            Question("qu_field_alerts_20", "qu_field_alerts", "Are timelines for FAR submission strictly monitored (initial <=3 working days, follow-up per investigation), with aging report/escalation for delays?", 20),
            Question("qu_field_alerts_21", "qu_field_alerts", "Are regulatory commitments from FARs (e.g., enhanced testing, process validation) tracked to closure via QMS with verification evidence?", 21),
            Question("qu_field_alerts_22", "qu_field_alerts", "Are personnel involved in FAR (coordinators, investigators) trained annually on SOP/21 CFR 314.81(b)(1) with competency quiz >=90% pass rate?", 22),
            Question("qu_field_alerts_23", "qu_field_alerts", "Are FARs (submitted + assessed) included in management review discussions quarterly, with trends and CAPA status reported?", 23),
            Question("qu_field_alerts_24", "qu_field_alerts", "Are near-miss events meeting FAR criteria if escalated (e.g., potential mix-up averted) monitored/trended, even if no submission required?", 24),
            Question("qu_field_alerts_25", "qu_field_alerts", "Are drug shortage implications (e.g., quality deviation during shortage) assessed during FAR decisions, with allocation risk documented?", 25),

            // Investigations
            Question("qu_investigations_1", "qu_investigations", "Do investigation SOPs explicitly reference and align with FDA's Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production (current version), including Phase 1A/1B lab investigation and Phase 2 manufacturing review?", 1),
            Question("qu_investigations_2", "qu_investigations", "Does the investigation SOP mandate use of structured root cause analysis (RCA) tools such as 5-Why (minimum 5 levels), Fishbone/Ishikawa diagram, or Fault Tree Analysis for all major/critical investigations?", 2),
            Question("qu_investigations_3", "qu_investigations", "Are investigations for OOS, deviations, and complaints initiated promptly (within 24h of detection) by QA personnel independent of the originating department, with automatic quarantine of affected material?", 3),
            Question("qu_investigations_4", "qu_investigations", "Are investigation hypotheses (e.g., lab error, process variation, equipment failure) scientifically sound, documented in a predefined protocol, and tested with evidence (data, literature references)?", 4),
            Question("qu_investigations_5", "qu_investigations", "Does QA checklist ensure investigations systematically address all potential failure modes (man, machine, method, material, measurement, environment) with none applicable explicitly justified?", 5),
            Question("qu_investigations_6", "qu_investigations", "Are investigation leads trained (initial and annual refresher) and qualified (successful mock investigations >=90%) as independent from routine operations, with current certification matrix?", 6),
            Question("qu_investigations_7", "qu_investigations", "When laboratory OOS is confirmed manufacturing-related (Phase 2), are investigations integrated with production records review, cross-functional input, and batch disposition recommendation?", 7),
            Question("qu_investigations_8", "qu_investigations", "Do current investigations include mandatory review of previous similar events (last 24 months) to prevent repeated root causes, with linkages or escalations documented?", 8),
            Question("qu_investigations_9", "qu_investigations", "Before QA approval, are the investigation bodies peer-reviewed for completeness (scope, data, rationale, conclusions) using a standardized checklist covering all SOP requirements?", 9),
            Question("qu_investigations_10", "qu_investigations", "Are operator/staff interview notes recorded contemporaneously during investigations, verbatim where possible, signed/dated by interviewee, and attached to the investigation report?", 10),
            Question("qu_investigations_11", "qu_investigations", "When investigations uncover undocumented practices (e.g., verbal instructions, unapproved workarounds), are they escalated as separate deviations or CAPAs with immediate interim controls?", 11),
            Question("qu_investigations_12", "qu_investigations", "For product/process investigations, are environmental (EM trends), equipment (maintenance logs, calibration), and utility data systematically reviewed and correlated with event timing?", 12),
            Question("qu_investigations_13", "qu_investigations", "Are failures attributed to human error supported by objective evidence (training records, qualification status, observation videos, multiple analysts affected) rather than default assumption?", 13),
            Question("qu_investigations_14", "qu_investigations", "Are investigation reports complete with all supporting attachments (equipment logs, chromatograms, EM data, pictures) traceable to time/location and reviewed for relevance?", 14),
            Question("qu_investigations_15", "qu_investigations", "Are no assignable cause conclusions scientifically justified with evidence of exhaustive investigation (all failure modes ruled out, statistical analysis confirming abnormality) per FDA OOS guidance?", 15),
            Question("qu_investigations_16", "qu_investigations", "Does QA reject and return investigations lacking evidence-based conclusions (e.g., generic training needed, unsubstantiated root causes) with documented reasons for rework?", 16),
            Question("qu_investigations_17", "qu_investigations", "Are investigation timelines tracked with justifications for extensions QA-approved and overdue aging report reviewed monthly?", 17),
            Question("qu_investigations_18", "qu_investigations", "Are closed investigations reopened when new evidence emerges (e.g., audit finding, complaint correlation) within defined criteria (e.g., within 1 year of closure) per SOP?", 18),
            Question("qu_investigations_19", "qu_investigations", "Is impact assessment for distributed batches (e.g., recall calculation, stability extrapolation, patient risk) documented with decision tree for field alert/reporting?", 19),
            Question("qu_investigations_20", "qu_investigations", "Does the site maintain an investigation knowledge repository/database (e.g., lessons learned database, searchable QMS module) accessible to investigators with annual update requirement?", 20),
            Question("qu_investigations_21", "qu_investigations", "When investigations identify systemic issues (recurring, multi-batch), are formal risk assessments (FMEA RPN>100) included with prioritized CAPA recommendations?", 21),
            Question("qu_investigations_22", "qu_investigations", "Does QA verify implementation and effectiveness of interim control measures (e.g., additional checks, 100% inspection) defined during open investigations before closure?", 22),
            Question("qu_investigations_23", "qu_investigations", "Are rejected/failed batches systematically linked to their root cause investigations with cross-references in batch records and APR for trend analysis?", 23),
            Question("qu_investigations_24", "qu_investigations", "Are investigation findings from corporate/sister sites leveraged through shared knowledge portals, with relevant lessons incorporated into local CAPA or training plans?", 24),
            Question("qu_investigations_25", "qu_investigations", "When applicable (OOS, complaints), are witness samples, retains, or duplicates included/analyzed in investigations with documented storage conditions and chain-of-custody?", 25),

            // Management Review & Quality Metrics
            Question("qu_mgmt_review_1", "qu_mgmt_review", "Is there an approved Standard Operating Procedure (SOP) that defines management review requirements, including agenda, attendees, frequency, inputs aligned with International Council for Harmonisation (ICH) guideline Q10, and action tracking?", 1),
            Question("qu_mgmt_review_2", "qu_mgmt_review", "Are management reviews conducted on a defined schedule - for example, monthly for operations, quarterly for quality, and annually for strategic reviews - with at least 95% adherence to the schedule?", 2),
            Question("qu_mgmt_review_3", "qu_mgmt_review", "Are quality metrics defined with clear calculation criteria, such as Out-of-Specification (OOS) rate calculated as OOS batches divided by total batches x100, with targets set at less than 1%, and data sources documented in the Key Performance Indicator (KPI) library?", 3),
            Question("qu_mgmt_review_4", "qu_mgmt_review", "Are deviations tracked by count and trend, Corrective and Preventive Actions (CAPAs) monitored to ensure overdue cases remain below 5% and effectiveness is at least 90%, complaints measured by rate per million units, and OOS trends graphed and discussed?", 4),
            Question("qu_mgmt_review_5", "qu_mgmt_review", "Are internal and external audit findings, including closure rates, and regulatory observations such as U.S. Food and Drug Administration (FDA) Form 483 responses, reviewed with current status updates?", 5),
            Question("qu_mgmt_review_6", "qu_mgmt_review", "Are KPI dashboards, such as real-time systems built in Power BI or Tableau, used for decision-making and covering at least 20 quality metrics?", 6),
            Question("qu_mgmt_review_7", "qu_mgmt_review", "Are recurring failures - defined as the same cause occurring three or more times within 12 months - highlighted with management action items assigned and escalated?", 7),
            Question("qu_mgmt_review_8", "qu_mgmt_review", "Are resource needs assessed, including staffing ratios such as one Quality Assurance (QA) staff per eight production staff, training budgets, and equipment capital expenditure (CAPEX), with identified gaps addressed?", 8),
            Question("qu_mgmt_review_9", "qu_mgmt_review", "Are process capability metrics, such as process capability index (Cpk) and process performance index (Ppk) maintained at >=1.33 for critical quality attributes (CQAs), reviewed using control charts for commercial products?", 9),
            Question("qu_mgmt_review_10", "qu_mgmt_review", "Are supplier performance indicators included in scorecards, such as on-time delivery >=98%, OOS results <2%, and audit scores >=90%?", 10),
            Question("qu_mgmt_review_11", "qu_mgmt_review", "Are in-process controls (IPC), such as yield and pH trends, and process control trends, such as Statistical Process Control (SPC) alarms, reviewed for stability?", 11),
            Question("qu_mgmt_review_12", "qu_mgmt_review", "Are product recalls and returns assessed for rate, root causes, and CAPA effectiveness, with preventive measures implemented?", 12),
            Question("qu_mgmt_review_13", "qu_mgmt_review", "Are quality risks reviewed and updated, including the top 10 risks in the Failure Mode and Effects Analysis (FMEA) register and residual Risk Priority Numbers (RPNs), with new mitigations applied?", 13),
            Question("qu_mgmt_review_14", "qu_mgmt_review", "Are market issues, such as shortages or competitor recalls impacting supply, escalated to top management with contingency plans?", 14),
            Question("qu_mgmt_review_15", "qu_mgmt_review", "Are improvement plans developed from Annual Product Quality Reviews (APQRs) and audits, tracked for completion >=90%, with owners and dates documented in the Quality Management System (QMS)?", 15),
            Question("qu_mgmt_review_16", "qu_mgmt_review", "Are environmental monitoring results reviewed, such as Grade A cleanroom limits of fewer than 1 colony-forming unit (CFU), and utilities monitored, such as Water for Injection (WFI) conductivity maintained below 1.3 microsiemens (S), with excursions tracked?", 16),
            Question("qu_mgmt_review_17", "qu_mgmt_review", "Are Quality Control (QC) laboratory metrics reviewed, such as test turnaround time (TAT) <=48 hours, analyst proficiency >=95%, and instrument uptime >=98%?", 17),
            Question("qu_mgmt_review_18", "qu_mgmt_review", "Are on-time batch release metrics assessed, such as >=95% of batches released within five days post-production, with bottlenecks identified?", 18),
            Question("qu_mgmt_review_19", "qu_mgmt_review", "Is production capacity utilization analyzed against quality issues, ensuring downtime due to quality problems remains below 10%?", 19),
            Question("qu_mgmt_review_20", "qu_mgmt_review", "Are trends in deviation misclassification or downgrading reviewed, ensuring audit findings remain below 5%, with training and CAPAs applied?", 20),
            Question("qu_mgmt_review_21", "qu_mgmt_review", "Is training performance reviewed, ensuring completion rates >=98% and overdue training <2%, with gaps addressed through action plans?", 21),
            Question("qu_mgmt_review_22", "qu_mgmt_review", "Is CAPA effectiveness examined, ensuring recurrence rates <5% and on-time closure >=95%, with underperforming CAPAs escalated?", 22),
            Question("qu_mgmt_review_23", "qu_mgmt_review", "Are regulatory commitments, such as inspection responses and product variations, reviewed for status and timelines?", 23),
            Question("qu_mgmt_review_24", "qu_mgmt_review", "Are cross-functional departments - including production, Quality Control (QC), Regulatory Affairs (RA), and supply chain - included in management review meetings, with attendance >=80%?", 24),
            Question("qu_mgmt_review_25", "qu_mgmt_review", "Are meeting minutes recorded, including attendees, metrics reviewed, decisions made, and action owners with dates, distributed within seven days, and followed up with >=90% completion?", 25),

            // Returned and Salvaged Drug Products
            Question("qu_returned_drugs_1", "qu_returned_drugs", "Is there an approved SOP covering receipt (immediate quarantine), evaluation (visual/analytical), disposition (destroy/reprocess/release), and documentation for all returned products?", 1),
            Question("qu_returned_drugs_2", "qu_returned_drugs", "Are returned goods logged within 24h with batch#/lot#, quantity returned, customer/distributor details, reason (damage/OOS/complaint), and receipt date?", 2),
            Question("qu_returned_drugs_3", "qu_returned_drugs", "Are returns quarantined (physically segregated >=2m, labeled RETURNED QUARANTINE lot#XYZ, restricted access) to prevent mix-ups with releasable stock upon receipt?", 3),
            Question("qu_returned_drugs_4", "qu_returned_drugs", "Are visual inspections (container integrity, labeling, tampering signs) performed/documented on 100% of returned containers by trained QA/warehouse personnel within 48h?", 4),
            Question("qu_returned_drugs_5", "qu_returned_drugs", "Are storage/transportation conditions reviewed (temp logs, chain of custody, shipping damage) for return justification, with excursion impact assessed?", 5),
            Question("qu_returned_drugs_6", "qu_returned_drugs", "Are returned goods assessed for tampering/counterfeiting (seal breach, holograms, serialization check) with escalation if suspected?", 6),
            Question("qu_returned_drugs_7", "qu_returned_drugs", "Are full quality investigations (per 211.192 if associated batches implicated) performed for each return reason (e.g., potency failure, contamination), with root cause?", 7),
            Question("qu_returned_drugs_8", "qu_returned_drugs", "Are microbiological risks (beyond-use stability, sterility breach potential) evaluated for sterile product returns via targeted testing/quarantine extension?", 8),
            Question("qu_returned_drugs_9", "qu_returned_drugs", "Are chemical/analytical assessments (assay, impurities, dissolution) performed on retains/returns when spec doubt exists, with compendial methods?", 9),
            Question("qu_returned_drugs_10", "qu_returned_drugs", "Are salvage operations prevented unless justified (lab data proving specs met) and approved by QA Head, with no disaster-exposed product salvaged?", 10),
            Question("qu_returned_drugs_11", "qu_returned_drugs", "Are salvage operations (rarely approved) documented with scientific rationale (test data, stability justification), QA approval, and full traceability?", 11),
            Question("qu_returned_drugs_12", "qu_returned_drugs", "Are wholesalers/distributors audited annually (GDP compliance, storage 15-25 degreesC, FIFO) to prevent improper storage contributing to returns?", 12),
            Question("qu_returned_drugs_13", "qu_returned_drugs", "Are decision outcomes (reprocess/rerelabel/destroy) documented with QA sign-off, rationale, and batch disposition within 30 days of receipt?", 13),
            Question("qu_returned_drugs_14", "qu_returned_drugs", "Are returned goods used for complaint investigation (side-by-side retain comparison) where applicable, with chain-of-custody maintained?", 14),
            Question("qu_returned_drugs_15", "qu_returned_drugs", "Is destruction of rejected returns documented (weighed, incinerated/rendered, witnessed by QA/production) with certificates retained >=1yr post-expiry?", 15),
            Question("qu_returned_drugs_16", "qu_returned_drugs", "Are returned goods data (volume, reasons, disposition) included in APQR trend analysis with root cause/Pareto for each product?", 16),
            Question("qu_returned_drugs_17", "qu_returned_drugs", "Are falsified/counterfeit returns escalated to regulatory authorities (FDA/EMA) within 24h with sample preservation for forensic analysis?", 17),
            Question("qu_returned_drugs_18", "qu_returned_drugs", "Are retesting/reprocessing decisions scientifically justified (stability data, risk assessment) with full validation before rerelabeling/release?", 18),
            Question("qu_returned_drugs_19", "qu_returned_drugs", "Are returned product samples retained (same conditions as product, 1yr post-expiry) for potential investigation/FAR?", 19),
            Question("qu_returned_drugs_20", "qu_returned_drugs", "Are returns evaluated for Field Alert Report (FAR) obligations per 21 CFR 314.81(b)(1) if distributed batches implicated?", 20),
            Question("qu_returned_drugs_21", "qu_returned_drugs", "Is segregation between returned and market stock ensured (separate racks/ERP status QUARANTINE RETURNED) with zero mix-ups verified monthly?", 21),
            Question("qu_returned_drugs_22", "qu_returned_drugs", "Are returned temperature-sensitive products evaluated using real-time stability data/excursion justification before any disposition?", 22),
            Question("qu_returned_drugs_23", "qu_returned_drugs", "Are discrepancies between returned quantities and distribution records (>5% variance) investigated as potential diversion/theft?", 23),
            Question("qu_returned_drugs_24", "qu_returned_drugs", "Are records of returns retained per GMP (name/potency, lot#, reason, qty, disposition date, ultimate fate) for >=1yr post-expiry?", 24),
            Question("qu_returned_drugs_25", "qu_returned_drugs", "Are return trends (quarterly by product/customer/reason) reviewed during management review with preventive actions assigned?", 25),

            // Quality Risk Management (QRM)
            Question("qu_risk_mgmt_1", "qu_risk_mgmt", "Is there a QRM SOP explicitly aligned with ICH Q9(R1) principles (risk assessment/control/review/communication) and FDA expectations, defining roles, tools (FMEA/HACCP), and documentation standards?", 1),
            Question("qu_risk_mgmt_2", "qu_risk_mgmt", "Are risk assessments performed using consistent, site-standardized tools (FMEA with RPN, HACCP CCPs, PHA hazard lists) per approved templates, with training required for facilitators?", 2),
            Question("qu_risk_mgmt_3", "qu_risk_mgmt", "Are risk assessments conducted proactively for new processes/equipment (before implementation) and not solely reactively after deviations, with >=80% proactive per annual QRM report?", 3),
            Question("qu_risk_mgmt_4", "qu_risk_mgmt", "Are severity (patient harm scale 1-10), occurrence (frequency 1-10), and detectability (control strength 1-10) clearly defined with site-specific justification tables and examples?", 4),
            Question("qu_risk_mgmt_5", "qu_risk_mgmt", "Are high-risk items (e.g., FMEA RPN>100, HACCP high severity) automatically escalated for mitigation actions with QA/management approval within 30 days?", 5),
            Question("qu_risk_mgmt_6", "qu_risk_mgmt", "Is a centralized risk register maintained/updated quarterly (all open risks listed, owners assigned, RPN tracked), accessible via QMS dashboard?", 6),
            Question("qu_risk_mgmt_7", "qu_risk_mgmt", "Are risk assessments periodically reviewed/updated (e.g., annually or post-change) with documented rationale for unchanged risks and mitigation progress tracked?", 7),
            Question("qu_risk_mgmt_8", "qu_risk_mgmt", "Is QA responsible for QRM oversight (facilitator qualification, template approval, final sign-off), ensuring science/risk-based decisions per governance SOP?", 8),
            Question("qu_risk_mgmt_9", "qu_risk_mgmt", "Are risk assessments linked to change control (pre/post RPN), deviations (triggered >RPN 50), and CAPA (mitigation actions) with bidirectional cross-references?", 9),
            Question("qu_risk_mgmt_10", "qu_risk_mgmt", "Are all major decisions (batch release, validation scope, supplier qualification) documented with science/risk justification referencing specific risk assessment output?", 10),
            Question("qu_risk_mgmt_11", "qu_risk_mgmt", "Are risk acceptance criteria clearly documented (e.g., RPN<50 acceptable, 50-100 monitor, >100 mitigate) and consistently applied across assessments?", 11),
            Question("qu_risk_mgmt_12", "qu_risk_mgmt", "Are high-impact risk assessments (sterile, potent API) conducted by cross-functional teams (min 4 departments: QA, production, QC, engineering) with attendance/roles documented?", 12),
            Question("qu_risk_mgmt_13", "qu_risk_mgmt", "Are risk mitigation plans tracked (owners, due dates, % complete) via QMS dashboard, with monthly reviews and escalations for delays >30 days?", 13),
            Question("qu_risk_mgmt_14", "qu_risk_mgmt", "Is residual risk post-mitigation quantitatively re-evaluated (new RPN calculated) and documented, confirming reduction to acceptable levels?", 14),
            Question("qu_risk_mgmt_15", "qu_risk_mgmt", "Are risks communicated to relevant personnel via training, dashboards, or SOPs, with acknowledgment/read receipts for critical risks (RPN>100)?", 15),
            Question("qu_risk_mgmt_16", "qu_risk_mgmt", "Are risks to data integrity (ALCOA+ violations, system access, manual transcription) explicitly included in QRM assessments for computerized systems and manual processes?", 16),
            Question("qu_risk_mgmt_17", "qu_risk_mgmt", "Is risk scoring reproducible across teams (inter-rater reliability >=85% agreement on RPN for test assessments) with calibration training/refresher annually?", 17),
            Question("qu_risk_mgmt_18", "qu_risk_mgmt", "Are special risks (sterility assurance >10 SAL, cross-contamination MAC/PDE, supply chain dual sourcing) addressed explicitly with dedicated FMEA/HACCP?", 18),
            Question("qu_risk_mgmt_19", "qu_risk_mgmt", "Are QRM templates standardized across departments (FMEA sheet format, scoring scales, output report) and approved/controlled by QA?", 19),
            Question("qu_risk_mgmt_20", "qu_risk_mgmt", "Are batch disposition decisions (release/hold) documented with risk assessment reference (e.g., deviation RPN reduced to 40 post-CAPA)?", 20),
            Question("qu_risk_mgmt_21", "qu_risk_mgmt", "Are completed risk assessments verified by QA for methodology compliance, scoring consistency, and mitigation feasibility before formal closure?", 21),
            Question("qu_risk_mgmt_22", "qu_risk_mgmt", "Are QRM outcomes (top risks, mitigation status) reviewed during Quality Management Review (QMR) meetings quarterly, with actions assigned?", 22),
            Question("qu_risk_mgmt_23", "qu_risk_mgmt", "Are new processes/equipment validated using QRM principles (prospective FMEA before IQ/OQ/PQ, critical controls defined)?", 23),
            Question("qu_risk_mgmt_24", "qu_risk_mgmt", "Are low-risk designations (RPN<20) justified with evidence (historical data, control strength, low severity) rather than assumption?", 24),
            Question("qu_risk_mgmt_25", "qu_risk_mgmt", "Are QRM failures (mitigation ineffective, risks materialized) trended quarterly for systemic QRM program improvement (training, tools, oversight)?", 25),

            // Supplier Quality Oversight
            Question("qu_supplier_1", "qu_supplier", "Is there an approved Standard Operating Procedure (SOP) that defines supplier qualification through questionnaires, audits, and testing; approval based on scorecards achieving at least 85%; and ongoing monitoring through annual reviews with scores maintained at or above 80%?", 1),
            Question("qu_supplier_2", "qu_supplier", "Are suppliers categorized by material criticality using a defined matrix - for example, critical suppliers of Active Pharmaceutical Ingredients (APIs) or key excipients audited annually; medium-risk excipient suppliers audited every two years; and low-risk packaging suppliers audited every three years?", 2),
            Question("qu_supplier_3", "qu_supplier", "Are supplier audits performed according to risk ranking - for example, critical suppliers audited at least annually with scores >=90, and on-site audits conducted when red flags are identified - with adherence to the audit schedule maintained at >=95%?", 3),
            Question("qu_supplier_4", "qu_supplier", "Are supplier Certificates of Analysis (CoAs) verified against in-house testing - for example, 100% identity testing, assay and impurity testing performed on a skip-lot basis for low-risk materials - according to an approved reduced testing plan?", 4),
            Question("qu_supplier_5", "qu_supplier", "Are material specifications communicated clearly to suppliers through approved technical packages that include monographs, tolerances, and Good Manufacturing Practice (GMP) requirements?", 5),
            Question("qu_supplier_6", "qu_supplier", "Are supplier change notifications - such as changes in site, process, or API source - evaluated under site change control procedures, with comparability data required to support approval?", 6),
            Question("qu_supplier_7", "qu_supplier", "Are suppliers monitored quarterly for performance metrics such as on-time delivery >=98%, right-first-time quality >=99%, and compliance with quality standards ensuring out-of-specification (OOS) results remain below 1%?", 7),
            Question("qu_supplier_8", "qu_supplier", "Are supplier performance scorecards maintained, incorporating audit results, on-time delivery (OTD), and quality scores, presented in weighted formats with red/amber/green color coding, and reviewed semi-annually?", 8),
            Question("qu_supplier_9", "qu_supplier", "Are new suppliers qualified through full assessments including 100% questionnaire completion, audits, full testing of the first three lots, and verification of GMP certification?", 9),
            Question("qu_supplier_10", "qu_supplier", "Are material complaints investigated jointly with suppliers, including root cause analysis and shared Corrective and Preventive Actions (CAPAs), particularly for critical suppliers?", 10),
            Question("qu_supplier_11", "qu_supplier", "Are suppliers required to provide lot traceability documentation - including Certificates of Analysis (CoA), Material of Construction (MoC) records, and batch genealogy trees - covering at least three generations back?", 11),
            Question("qu_supplier_12", "qu_supplier", "Are supplier GMP certificates and regulatory inspection results - such as U.S. Food and Drug Administration (FDA) or European Medicines Agency (EMA) Form 483 observations - reviewed annually, with contractual rights to audit included?", 12),
            Question("qu_supplier_13", "qu_supplier", "Are supplier Corrective and Preventive Actions (CAPAs) reviewed for adequacy, ensuring closure within 90 days, effectiveness supported by data, and recurrence prevention before acceptance?", 13),
            Question("qu_supplier_14", "qu_supplier", "Are fraudulent or suspect materials - such as tampered seals or mismatched Certificates of Analysis (CoAs) - escalated to Quality Assurance (QA), Regulatory Affairs (RA), and regulators within 24 hours, with immediate quarantine applied?", 14),
            Question("qu_supplier_15", "qu_supplier", "Are alternate or backup suppliers evaluated for risk, with parallel qualification and dual sourcing implemented for critical APIs covering at least 50% of supply?", 15),
            Question("qu_supplier_16", "qu_supplier", "Are raw material testing frequencies justified through risk-based SOPs - for example, skip-lot testing permitted for low-risk materials with >=6 months of stability data, while identity testing remains at 100%?", 16),
            Question("qu_supplier_17", "qu_supplier", "Are Technical and Quality Agreements maintained and updated annually for critical suppliers, covering specifications, change management, audit requirements, and rejection authority?", 17),
            Question("qu_supplier_18", "qu_supplier", "Are audit findings communicated clearly to suppliers, with rated reports issued within 14 days and CAPA responses required within 30 days, tracked to closure?", 18),
            Question("qu_supplier_19", "qu_supplier", "Are supplier-related trends - such as out-of-specification (OOS) results or late deliveries - included in product Annual Product Quality Reviews (APQRs), with preventive actions documented?", 19),
            Question("qu_supplier_20", "qu_supplier", "Are supplier risks - such as single-source dependency or geopolitical concerns - included in the site risk register, with Failure Mode and Effects Analysis (FMEA) updated quarterly?", 20),
            Question("qu_supplier_21", "qu_supplier", "Are transportation and logistics partners qualified through Good Distribution Practice (GDP) audits, temperature validation studies confirming 2-8 degreesC control for 96 hours, and contingency planning?", 21),
            Question("qu_supplier_22", "qu_supplier", "Are packaging supplier controls reviewed, including ink migration testing (<10 parts per billion), laminate delamination testing, and foil pinhole testing with Acceptance Quality Limit (AQL) of 0.65?", 22),
            Question("qu_supplier_23", "qu_supplier", "Are cold chain suppliers qualified based on thermal mapping, using validated shippers that maintain 2-8 degreesC, with data loggers calibrated to +/-0.5 degreesC?", 23),
            Question("qu_supplier_24", "qu_supplier", "Are material quarantine rules applied to supplier failures - such as non-conforming Certificates of Analysis (CoAs) or audit red flags - until issues are resolved?", 24),
            Question("qu_supplier_25", "qu_supplier", "Are supplier Key Performance Indicators (KPIs) - such as on-time delivery >=98% and quality compliance >=99% - reviewed quarterly during management reviews, with delisting actions taken when performance falls below thresholds?", 25),

            // Technology Transfer Oversight
            Question("qu_tech_transfer_1", "qu_tech_transfer", "Is there an approved TT SOP covering development-to-commercial and site-to-site transfers, defining stages (knowledge transfer, scale-up, validation, PPQ oversight)?", 1),
            Question("qu_tech_transfer_2", "qu_tech_transfer", "Are TT teams cross-functional (R&D/formulation, Manufacturing, QA, QC, Engineering/RA) with defined roles, >=5 members, and kickoff charter signed?", 2),
            Question("qu_tech_transfer_3", "qu_tech_transfer", "Is process knowledge (CPPs/CQAs, design space, historical data) and critical parameters transferred in documented format (Tech Transfer Package/Dossier)?", 3),
            Question("qu_tech_transfer_4", "qu_tech_transfer", "Are scale-up risks (heat/mass transfer, mixing) evaluated/documented via FMEA (RPN prioritized) pre-pilot batches?", 4),
            Question("qu_tech_transfer_5", "qu_tech_transfer", "Are prospective risk assessments (FMEA/PHA) performed at TT milestones (lab->pilot->commercial) with residual risk tracked?", 5),
            Question("qu_tech_transfer_6", "qu_tech_transfer", "Are analytical methods validated (sending site ICH Q2) or verified (receiving equivalence >=95% accuracy) before TT completion?", 6),
            Question("qu_tech_transfer_7", "qu_tech_transfer", "Are equipment comparability studies (ribbon blender vs high shear, ribbon vs V-blender torque) performed between sending/receiving sites?", 7),
            Question("qu_tech_transfer_8", "qu_tech_transfer", "Are cleaning requirements (worst-case, MAC/PDE) assessed during TT, with bracketing/matrixing justified for receiving site?", 8),
            Question("qu_tech_transfer_9", "qu_tech_transfer", "Are cleaning validation limits (swab/rinse, visuals) reassessed for TT scale/equipment changes pre-commercial?", 9),
            Question("qu_tech_transfer_10", "qu_tech_transfer", "Are Hold Time studies (dirty/clean equipment, in-process intermediates) transferred and verified at receiving site (challenge max hold)?", 10),
            Question("qu_tech_transfer_11", "qu_tech_transfer", "Are >=3 engineering batches planned/executed at target scale with QA oversight (real-time review, deviation control)?", 11),
            Question("qu_tech_transfer_12", "qu_tech_transfer", "Are process control strategies (PAT, in-process limits, alarms) established/verified during TT engineering runs?", 12),
            Question("qu_tech_transfer_13", "qu_tech_transfer", "Are Technology Transfer Reports (summary data, gaps closed, readiness) reviewed/approved by QA before PPQ?", 13),
            Question("qu_tech_transfer_14", "qu_tech_transfer", "Are PPQ batches (>=3 consecutive) planned with TT oversight (sending site support, enhanced sampling)?", 14),
            Question("qu_tech_transfer_15", "qu_tech_transfer", "Are material attribute differences (API PSD, excipient grade, supplier) assessed with comparability protocols pre-TT?", 15),
            Question("qu_tech_transfer_16", "qu_tech_transfer", "Are in-process/product sampling plans reassessed during TT for scale (stat power >=90%)?", 16),
            Question("qu_tech_transfer_17", "qu_tech_transfer", "Are deviations during TT trended (by phase, root cause) for learnings incorporated into commercial process?", 17),
            Question("qu_tech_transfer_18", "qu_tech_transfer", "Are training requirements defined for receiving operators (SOPs, OJT, >=40h) with qualification >=90% competency pre-PPQ?", 18),
            Question("qu_tech_transfer_19", "qu_tech_transfer", "Are scale-up deviations (yield <90%, OOS) escalated to TT team/QA for immediate disposition?", 19),
            Question("qu_tech_transfer_20", "qu_tech_transfer", "Are TT documents (protocols, data, reports) controlled (unique IDs, versions) and archived >= product lifecycle +1yr?", 20),
            Question("qu_tech_transfer_21", "qu_tech_transfer", "Are equipment gaps (no high shear mixer) identified/mitigated (protocol equivalence, rental validation) before TT?", 21),
            Question("qu_tech_transfer_22", "qu_tech_transfer", "Are utilities (HVAC, WFI, compressed air) assessed for suitability (qualify, microbial specs) at receiving site pre-TT?", 22),
            Question("qu_tech_transfer_23", "qu_tech_transfer", "Are initial 3 commercial batches monitored more frequently (daily IPC, enhanced QC release) post-TT?", 23),
            Question("qu_tech_transfer_24", "qu_tech_transfer", "Is process robustness data (CPV stage 1, historical) reviewed during TT to set commercial controls?", 24),
            Question("qu_tech_transfer_25", "qu_tech_transfer", "Are TT activities (scale factors, minor tweaks) linked to change controls with regulatory assessment?", 25),

            // Training Management
            Question("qu_training_1", "qu_training", "Is there an approved training SOP defining competency (knowledge+skills), qualification (On-Job Training/assessment), retraining triggers (SOP change, incident, 2yrs), and documentation standards?", 1),
            Question("qu_training_2", "qu_training", "Are department-specific training matrices maintained (current, electronic/paper, >=95% completion rate), updated quarterly, and signed by managers/QA with gap alerts?", 2),
            Question("qu_training_3", "qu_training", "Are training records complete (attendee, trainer, date, content/version, assessment score), contemporaneous (signed same day), and audit-ready (retrievable <30min)?", 3),
            Question("qu_training_4", "qu_training", "Are new employees completing Phase I/II GMP orientation + job-specific training (>=40h) and qualified before independent GxP activities, per probation checklist?", 4),
            Question("qu_training_5", "qu_training", "Are critical GxP operations (aseptic filling, weighing, deviations) restricted to qualified personnel only, verified via badge/swipe access or supervisor log?", 5),
            Question("qu_training_6", "qu_training", "Are periodic refresher trainings scheduled/tracked (annual GMP awareness, 2yr job-specific) with automated LMS reminders and <=5% overdue rate?", 6),
            Question("qu_training_7", "qu_training", "Are effectiveness checks performed for critical/CAPA-linked training (post-quiz >=90%, observation audit, KPI improvement) within 90 days of delivery?", 7),
            Question("qu_training_8", "qu_training", "Upon SOP revision, are affected personnel retrained (read+acknowledge <=30 days effective date) with completion >=95% before using new version?", 8),
            Question("qu_training_9", "qu_training", "Are on-the-job training (OJT) sessions documented with qualified trainer signatures, trainee competency checklist (>=90% steps demonstrated), and supervisor verification?", 9),
            Question("qu_training_10", "qu_training", "Are training courses reviewed annually for relevance/accuracy (SME sign-off, post-training feedback >=80% satisfaction) with obsolete content updated?", 10),
            Question("qu_training_11", "qu_training", "Are e-learning modules validated (content accuracy, LMS tracking completion/tests, no unauthorized skips) with periodic review (annual quiz refresh)?", 11),
            Question("qu_training_12", "qu_training", "Are training gaps identified in OOS/deviations/CAPA addressed via targeted retraining with effectiveness verification before closure?", 12),
            Question("qu_training_13", "qu_training", "Are temporary staff/contractors trained equivalently to full-time (matrix inclusion, qualification before GxP work) with access revoked post-contract?", 13),
            Question("qu_training_14", "qu_training", "Are consultants/contractors included in training program (site induction, job SOPs, qualification) with records retained >= contract duration +1yr?", 14),
            Question("qu_training_15", "qu_training", "Are training facilities adequate (quiet, GMP visuals, audio-visual equipment functional) and free from distractions, verified by annual facility audit?", 15),
            Question("qu_training_16", "qu_training", "Are training records protected from manipulation (electronic Part 11 audit trails, paper locked storage) with access logs reviewed semi-annually?", 16),
            Question("qu_training_17", "qu_training", "Are personnel requalified after prolonged inactivity (>3 months critical operations, >6 months routine) via refresher+OJT before resuming GxP duties?", 17),
            Question("qu_training_18", "qu_training", "Are training effectiveness quizzes scientifically designed (>=20 validated questions, >=80% pass, psychometrics reviewed annually) for critical roles?", 18),
            Question("qu_training_19", "qu_training", "Is training data (completion rates, scores) integrated into performance management (appraisals, promotions) with low performers (<80% compliance) coached?", 19),
            Question("qu_training_20", "qu_training", "Are continuous learning programs available (quarterly GMP refreshers, annual compliance trends webinars) with >=4h/year participation tracked per employee?", 20),
            Question("qu_training_21", "qu_training", "Are training KPIs monitored monthly (overdue <5%, competency >=90%, effectiveness >=85%) via dashboard reviewed in Quality Management Review?", 21),
            Question("qu_training_22", "qu_training", "Are supervisors accountable for team training completion (sign matrix monthly, escalate gaps), with non-compliance linked to performance metrics?", 22),
            Question("qu_training_23", "qu_training", "Are job descriptions aligned with competency requirements (specific trainings listed), reviewed annually with HR/QA approval?", 23),
            Question("qu_training_24", "qu_training", "Are critical quality incidents (OOS clusters, deviations) used for targeted retraining (root cause training gaps) with effectiveness pre-closure verification?", 24),
            Question("qu_training_25", "qu_training", "Are training files (matrices, records, gaps) proactively included in regulatory audit preparation packages with mock audit readiness >=95%?", 25),

            // Batch Records
            Question("pr_batch_records_1", "pr_batch_records", "Are batch records user-friendly, clear, and GMP-compliant?", 1),
            Question("pr_batch_records_2", "pr_batch_records", "Are instructions unambiguous with step-by-step guidance?", 2),
            Question("pr_batch_records_3", "pr_batch_records", "Are actual values recorded, not ranges, unless justified?", 3),
            Question("pr_batch_records_4", "pr_batch_records", "Are entries contemporaneous and signed immediately after execution?", 4),
            Question("pr_batch_records_5", "pr_batch_records", "Are sections for yield, weights, and signatures complete?", 5),
            Question("pr_batch_records_6", "pr_batch_records", "Are overwrites corrected per GDP rules?", 6),
            Question("pr_batch_records_7", "pr_batch_records", "Are batch records reviewed by QA within defined timelines?", 7),
            Question("pr_batch_records_8", "pr_batch_records", "Are critical steps requiring second-person verification clearly marked?", 8),
            Question("pr_batch_records_9", "pr_batch_records", "Are photocopies prohibited in official batch records?", 9),
            Question("pr_batch_records_10", "pr_batch_records", "Are all deviations referenced correctly in the batch record?", 10),
            Question("pr_batch_records_11", "pr_batch_records", "Are version numbers controlled and visible?", 11),
            Question("pr_batch_records_12", "pr_batch_records", "Are logbooks referenced where required?", 12),
            Question("pr_batch_records_13", "pr_batch_records", "Are batch records protected from damage or loss?", 13),
            Question("pr_batch_records_14", "pr_batch_records", "Are  electronic batch records Part 11 compliant?", 14),
            Question("pr_batch_records_15", "pr_batch_records", "Are attachments (EM results, labels, printouts) included and traceable?", 15),
            Question("pr_batch_records_16", "pr_batch_records", "Are mistakes  analyzed  for training opportunities?", 16),
            Question("pr_batch_records_17", "pr_batch_records", "Are yield calculations checked independently?", 17),
            Question("pr_batch_records_18", "pr_batch_records", "Are time gaps explained (breaks, halts)?", 18),
            Question("pr_batch_records_19", "pr_batch_records", "Are  sampling details recorded accurately?", 19),
            Question("pr_batch_records_20", "pr_batch_records", "Are large blank spaces avoided to prevent misuse?", 20),
            Question("pr_batch_records_21", "pr_batch_records", "Are material lot numbers traceable?", 21),
            Question("pr_batch_records_22", "pr_batch_records", "Are equipment IDs traceable to cleaning records?", 22),
            Question("pr_batch_records_23", "pr_batch_records", "Are critical alarms or stoppages documented?", 23),
            Question("pr_batch_records_24", "pr_batch_records", "Are reconciliation entries complete for all materials?", 24),
            Question("pr_batch_records_25", "pr_batch_records", "Are master batch records periodically reviewed and updated?", 25),

            // Batch Release
            Question("pr_batch_release_1", "pr_batch_release", "Are QA reviewers independent from production?", 1),
            Question("pr_batch_release_2", "pr_batch_release", "Are release decisions based on complete review of batch and test records?", 2),
            Question("pr_batch_release_3", "pr_batch_release", "Are deviations and CAPAs related to the batch fully closed?", 3),
            Question("pr_batch_release_4", "pr_batch_release", "Are trend excursions reviewed before release?", 4),
            Question("pr_batch_release_5", "pr_batch_release", "Are  certificate of analysis entries verified?", 5),
            Question("pr_batch_release_6", "pr_batch_release", "Are  sampling procedures followed correctly?", 6),
            Question("pr_batch_release_7", "pr_batch_release", "Are retain samples verified for quantity and integrity?", 7),
            Question("pr_batch_release_8", "pr_batch_release", "Are analytical results compared against historical trends?", 8),
            Question("pr_batch_release_9", "pr_batch_release", "Are line clearance records part of the review?", 9),
            Question("pr_batch_release_10", "pr_batch_release", "Are electronic signatures validated?", 10),
            Question("pr_batch_release_11", "pr_batch_release", "Are stability data reviewed when needed?", 11),
            Question("pr_batch_release_12", "pr_batch_release", "Are packaging operations verified through reconciliation?", 12),
            Question("pr_batch_release_13", "pr_batch_release", "Are  environmental monitoring data checked for batch impact?", 13),
            Question("pr_batch_release_14", "pr_batch_release", "Are vendor COAs checked against internal results?", 14),
            Question("pr_batch_release_15", "pr_batch_release", "Are yield variations investigated before release?", 15),
            Question("pr_batch_release_16", "pr_batch_release", "Are reworks/reprocess steps reviewed?", 16),
            Question("pr_batch_release_17", "pr_batch_release", "Are pre-approval batches handled differently as per SOP?", 17),
            Question("pr_batch_release_18", "pr_batch_release", "Are supply chain risks assessed for released batches?", 18),
            Question("pr_batch_release_19", "pr_batch_release", "Are release timelines tracked?", 19),
            Question("pr_batch_release_20", "pr_batch_release", "Are out-of-trend results evaluated?", 20),
            Question("pr_batch_release_21", "pr_batch_release", "Are market complaints fed back into release decisions?", 21),
            Question("pr_batch_release_22", "pr_batch_release", "Are critical alarms reviewed?", 22),
            Question("pr_batch_release_23", "pr_batch_release", "Are  cleaning records reviewed for equipment used?", 23),
            Question("pr_batch_release_24", "pr_batch_release", "Are deviations escalated when required?", 24),
            Question("pr_batch_release_25", "pr_batch_release", "Are batch release records archived securely?", 25),

            // Cleaning Validation
            Question("pr_cleaning_val_1", "pr_cleaning_val", "Is there a site-wide cleaning validation policy based on worst-case product selection?", 1),
            Question("pr_cleaning_val_2", "pr_cleaning_val", "Are MACO (Maximum Allowable Carryover) limits scientifically calculated?", 2),
            Question("pr_cleaning_val_3", "pr_cleaning_val", "Are swab and rinse recovery studies performed and validated?", 3),
            Question("pr_cleaning_val_4", "pr_cleaning_val", "Are dirty-hold and clean-hold times validated?", 4),
            Question("pr_cleaning_val_5", "pr_cleaning_val", "Are rinse volumes standardized and documented?", 5),
            Question("pr_cleaning_val_6", "pr_cleaning_val", "Are visually clean acceptance criteria defined?", 6),
            Question("pr_cleaning_val_7", "pr_cleaning_val", "Are dedicated vs. multiproduct equipment decisions risk-based?", 7),
            Question("pr_cleaning_val_8", "pr_cleaning_val", "Are hard-to-clean areas identified and included in validation?", 8),
            Question("pr_cleaning_val_9", "pr_cleaning_val", "Are  cleaning agents qualified for effectiveness and compatibility?", 9),
            Question("pr_cleaning_val_10", "pr_cleaning_val", "Are  sampling locations justified scientifically?", 10),
            Question("pr_cleaning_val_11", "pr_cleaning_val", "Are analytical methods for residue testing validated?", 11),
            Question("pr_cleaning_val_12", "pr_cleaning_val", "Are tough-to-clean residues identified from degradation studies?", 12),
            Question("pr_cleaning_val_13", "pr_cleaning_val", "Are  cleaning failures documented under deviations?", 13),
            Question("pr_cleaning_val_14", "pr_cleaning_val", "Are CIP/SIP cycles validated for time, temperature, flow?", 14),
            Question("pr_cleaning_val_15", "pr_cleaning_val", "Are disassembly requirements specified clearly?", 15),
            Question("pr_cleaning_val_16", "pr_cleaning_val", "Are swab materials validated for extraction efficiency?", 16),
            Question("pr_cleaning_val_17", "pr_cleaning_val", "Are cycles monitored for consistency between batches?", 17),
            Question("pr_cleaning_val_18", "pr_cleaning_val", "Are equipment interior surfaces inspected for stains or residues?", 18),
            Question("pr_cleaning_val_19", "pr_cleaning_val", "Are lifecycle revalidation criteria defined?", 19),
            Question("pr_cleaning_val_20", "pr_cleaning_val", "Are cleaning validation acceptance criteria aligned with regulatory guidance?", 20),
            Question("pr_cleaning_val_21", "pr_cleaning_val", "Are product contact parts traceable to cleaning records?", 21),
            Question("pr_cleaning_val_22", "pr_cleaning_val", "Are bracketing/matrixing approaches justified?", 22),
            Question("pr_cleaning_val_23", "pr_cleaning_val", "Are rinse samples stored and handled under validated conditions?", 23),
            Question("pr_cleaning_val_24", "pr_cleaning_val", "Are training records available for cleaning operators?", 24),
            Question("pr_cleaning_val_25", "pr_cleaning_val", "Are cleaning validation reports part of regulatory inspection readiness?", 25),

            // Contamination Control
            Question("pr_contamination_1", "pr_contamination", "Is there a written contamination control strategy integrating facility, equipment, personnel, and process risks?", 1),
            Question("pr_contamination_2", "pr_contamination", "Are dirty and clean material flows fully segregated?", 2),
            Question("pr_contamination_3", "pr_contamination", "Are personnel movement pathways mapped and enforced?", 3),
            Question("pr_contamination_4", "pr_contamination", "Are  environmental monitoring results reviewed for contamination patterns?", 4),
            Question("pr_contamination_5", "pr_contamination", "Are gowning practices observed and audited regularly?", 5),
            Question("pr_contamination_6", "pr_contamination", "Are  cleaning procedures validated for worst-case residues?", 6),
            Question("pr_contamination_7", "pr_contamination", "Are operators trained to avoid hand-product contact?", 7),
            Question("pr_contamination_8", "pr_contamination", "Are open product exposure times minimized and justified?", 8),
            Question("pr_contamination_9", "pr_contamination", "Are manufacturing rooms under appropriate pressure differentials?", 9),
            Question("pr_contamination_10", "pr_contamination", "Are HEPA filters leak-tested at defined frequency?", 10),
            Question("pr_contamination_11", "pr_contamination", "Are disinfectants rotated and validated for microbial efficacy?", 11),
            Question("pr_contamination_12", "pr_contamination", "Are materials disinfected before entering controlled areas?", 12),
            Question("pr_contamination_13", "pr_contamination", "Are pest control measures documented?", 13),
            Question("pr_contamination_14", "pr_contamination", "Are equipment surfaces inspected for cleanliness before each batch?", 14),
            Question("pr_contamination_15", "pr_contamination", "Are waste bins closed,  labeled , and removed frequently?", 15),
            Question("pr_contamination_16", "pr_contamination", "Are interventions during aseptic operations minimized and monitored?", 16),
            Question("pr_contamination_17", "pr_contamination", "Are vents and drains protected against contamination risks?", 17),
            Question("pr_contamination_18", "pr_contamination", "Are hoses and connectors protected when not in use?", 18),
            Question("pr_contamination_19", "pr_contamination", "Are compressed gases filtered and tested for microbial quality?", 19),
            Question("pr_contamination_20", "pr_contamination", "Are open drains avoided in classified areas?", 20),
            Question("pr_contamination_21", "pr_contamination", "Are room classifications verified through periodic requalification?", 21),
            Question("pr_contamination_22", "pr_contamination", "Are microbial excursions investigated promptly?", 22),
            Question("pr_contamination_23", "pr_contamination", "Are allergenic or sensitizing products segregated?", 23),
            Question("pr_contamination_24", "pr_contamination", "Are cross-contamination risks assessed for multiproduct facilities?", 24),
            Question("pr_contamination_25", "pr_contamination", "Is contamination control included in training and competency assessments?", 25),

            // In-Process Controls (IPC)

            // Batch Manufacturing
            Question("pr_manufacturing_1", "pr_manufacturing", "Are manufacturing areas prepared and cleaned before batch start?", 1),
            Question("pr_manufacturing_2", "pr_manufacturing", "Are raw materials verified against dispensing records?", 2),
            Question("pr_manufacturing_3", "pr_manufacturing", "Are equipment IDs documented clearly?", 3),
            Question("pr_manufacturing_4", "pr_manufacturing", "Are start/end times recorded accurately?", 4),
            Question("pr_manufacturing_5", "pr_manufacturing", "Are mixing speeds and times monitored?", 5),
            Question("pr_manufacturing_6", "pr_manufacturing", "Are manual  weighings  double-checked?", 6),
            Question("pr_manufacturing_7", "pr_manufacturing", "Are in-process stages signed step-by-step?", 7),
            Question("pr_manufacturing_8", "pr_manufacturing", "Are sifting/milling parameters monitored?", 8),
            Question("pr_manufacturing_9", "pr_manufacturing", "Are  open handling steps minimized?", 9),
            Question("pr_manufacturing_10", "pr_manufacturing", "Are sieves inspected before use?", 10),
            Question("pr_manufacturing_11", "pr_manufacturing", "Are intermediate yields calculated accurately?", 11),
            Question("pr_manufacturing_12", "pr_manufacturing", "Are deviations recorded immediately?", 12),
            Question("pr_manufacturing_13", "pr_manufacturing", "Are cleaning between batches verified?", 13),
            Question("pr_manufacturing_14", "pr_manufacturing", "Are product touches avoided?", 14),
            Question("pr_manufacturing_15", "pr_manufacturing", "Are allergen controls followed where applicable?", 15),
            Question("pr_manufacturing_16", "pr_manufacturing", "Are temperatures recorded for heat-sensitive operations?", 16),
            Question("pr_manufacturing_17", "pr_manufacturing", "Are alarms documented?", 17),
            Question("pr_manufacturing_18", "pr_manufacturing", "Are fluid bed dryer conditions monitored?", 18),
            Question("pr_manufacturing_19", "pr_manufacturing", "Are granulations evaluated for uniformity?", 19),
            Question("pr_manufacturing_20", "pr_manufacturing", "Are compression machines run under validated conditions?", 20),
            Question("pr_manufacturing_21", "pr_manufacturing", "Are lubrication steps monitored?", 21),
            Question("pr_manufacturing_22", "pr_manufacturing", "Are blend homogeneity tests performed?", 22),
            Question("pr_manufacturing_23", "pr_manufacturing", "Are  sampling points justified?", 23),
            Question("pr_manufacturing_24", "pr_manufacturing", "Are OOS/OOT IPC values investigated?", 24),
            Question("pr_manufacturing_25", "pr_manufacturing", "Are batch manufacturing steps audited regularly?", 25),

            // Master Production Records & Instructions
            Question("pr_master_records_1", "pr_master_records", "Are MPRs approved by QA and version-controlled?", 1),
            Question("pr_master_records_2", "pr_master_records", "Are instructions written in simple, unambiguous language?", 2),
            Question("pr_master_records_3", "pr_master_records", "Are equipment IDs included for each step?", 3),
            Question("pr_master_records_4", "pr_master_records", "Are theoretical yields and ranges defined?", 4),
            Question("pr_master_records_5", "pr_master_records", "Are  sampling instructions detailed?", 5),
            Question("pr_master_records_6", "pr_master_records", "Are  cleaning requirements specified?", 6),
            Question("pr_master_records_7", "pr_master_records", "Are in-process tests included with acceptance criteria?", 7),
            Question("pr_master_records_8", "pr_master_records", "Are critical steps requiring verification highlighted?", 8),
            Question("pr_master_records_9", "pr_master_records", "Are safety warnings included?", 9),
            Question("pr_master_records_10", "pr_master_records", "Are MPRs periodically reviewed?", 10),
            Question("pr_master_records_11", "pr_master_records", "Are rework procedures included or cross-referenced?", 11),
            Question("pr_master_records_12", "pr_master_records", "Are process flow diagrams included where helpful?", 12),
            Question("pr_master_records_13", "pr_master_records", "Are  allowable manufacturing variations defined?", 13),
            Question("pr_master_records_14", "pr_master_records", "Are hold times and storage conditions documented?", 14),
            Question("pr_master_records_15", "pr_master_records", "Are SOP references correct and current?", 15),
            Question("pr_master_records_16", "pr_master_records", "Are  formulation details correct across versions?", 16),
            Question("pr_master_records_17", "pr_master_records", "Are change controls documented for every revision?", 17),
            Question("pr_master_records_18", "pr_master_records", "Are MPRs available at point of use?", 18),
            Question("pr_master_records_19", "pr_master_records", "Are printing of MPRs controlled?", 19),
            Question("pr_master_records_20", "pr_master_records", "Are tables and charts clear and legible?", 20),
            Question("pr_master_records_21", "pr_master_records", "Are calculation steps included where needed?", 21),
            Question("pr_master_records_22", "pr_master_records", "Are cross-references to packaging records made?", 22),
            Question("pr_master_records_23", "pr_master_records", "Are limits for alarms/alerts included?", 23),
            Question("pr_master_records_24", "pr_master_records", "Are raw material quantities double-checked?", 24),
            Question("pr_master_records_25", "pr_master_records", "Are historical deviations used to improve MPR clarity?", 25),

            // Media Fills
            Question("pr_media_fills_1", "pr_media_fills", "Is there a validated media fill program aligned with aseptic processing guidance?", 1),
            Question("pr_media_fills_2", "pr_media_fills", "Are worst-case conditions (maximum fills, slow lines) included?", 2),
            Question("pr_media_fills_3", "pr_media_fills", "Are interventions categorized and simulated realistically?", 3),
            Question("pr_media_fills_4", "pr_media_fills", "Are media fill run durations representative of commercial runs?", 4),
            Question("pr_media_fills_5", "pr_media_fills", "Are operator interventions logged and  analyzed ?", 5),
            Question("pr_media_fills_6", "pr_media_fills", "Are environmental excursions tracked during media fills?", 6),
            Question("pr_media_fills_7", "pr_media_fills", "Is growth media validated for fertility and selectivity?", 7),
            Question("pr_media_fills_8", "pr_media_fills", "Are fill lines sanitized and sterilized using validated methods?", 8),
            Question("pr_media_fills_9", "pr_media_fills", "Are units incubated under defined conditions?", 9),
            Question("pr_media_fills_10", "pr_media_fills", "Are incubation records complete and reviewable?", 10),
            Question("pr_media_fills_11", "pr_media_fills", "Are media fills repeated after major equipment changes?", 11),
            Question("pr_media_fills_12", "pr_media_fills", "Are contamination events investigated thoroughly?", 12),
            Question("pr_media_fills_13", "pr_media_fills", "Are operators qualified based on media fill performance?", 13),
            Question("pr_media_fills_14", "pr_media_fills", "Are worst-case container/closure types included?", 14),
            Question("pr_media_fills_15", "pr_media_fills", "Are loading and unloading processes simulated?", 15),
            Question("pr_media_fills_16", "pr_media_fills", "Are glove integrity tests performed before/after media fill?", 16),
            Question("pr_media_fills_17", "pr_media_fills", "Are slowest speeds included in simulation?", 17),
            Question("pr_media_fills_18", "pr_media_fills", "Are fill needles/paths challenged for contamination risk?", 18),
            Question("pr_media_fills_19", "pr_media_fills", "Are reject units examined for contamination evidence?", 19),
            Question("pr_media_fills_20", "pr_media_fills", "Are failure rates within acceptable regulatory ranges?", 20),
            Question("pr_media_fills_21", "pr_media_fills", "Are excursions documented and risk assessed?", 21),
            Question("pr_media_fills_22", "pr_media_fills", "Are trend analyses performed across multiple media fills?", 22),
            Question("pr_media_fills_23", "pr_media_fills", "Are seasonal variations considered in design?", 23),
            Question("pr_media_fills_24", "pr_media_fills", "Are media fill acceptance criteria defined?", 24),
            Question("pr_media_fills_25", "pr_media_fills", "Are media fills included in annual aseptic qualification?", 25),

            // Process Monitoring
            Question("pr_monitoring_1", "pr_monitoring", "Are IPC results reviewed during manufacturing?", 1),
            Question("pr_monitoring_2", "pr_monitoring", "Are PAT (Process Analytical Technology) tools validated?", 2),
            Question("pr_monitoring_3", "pr_monitoring", "Are process parameters trended for drift?", 3),
            Question("pr_monitoring_4", "pr_monitoring", "Are charts and graphs reviewed by supervisors?", 4),
            Question("pr_monitoring_5", "pr_monitoring", "Are critical instruments monitored for calibration status?", 5),
            Question("pr_monitoring_6", "pr_monitoring", "Are batch yields monitored for variation?", 6),
            Question("pr_monitoring_7", "pr_monitoring", "Are in-process samples traceable?", 7),
            Question("pr_monitoring_8", "pr_monitoring", "Are microbial IPC checks conducted for sterile processes?", 8),
            Question("pr_monitoring_9", "pr_monitoring", "Are IPC failures escalated?", 9),
            Question("pr_monitoring_10", "pr_monitoring", "Are particle size/moisture tests  trended ?", 10),
            Question("pr_monitoring_11", "pr_monitoring", "Are blending uniformity checks performed?", 11),
            Question("pr_monitoring_12", "pr_monitoring", "Are SPI (statistical process indicators) used appropriately?", 12),
            Question("pr_monitoring_13", "pr_monitoring", "Are pH and viscosity results monitored continuously?", 13),
            Question("pr_monitoring_14", "pr_monitoring", "Are IPC instruments controlled and maintained?", 14),
            Question("pr_monitoring_15", "pr_monitoring", "Are excursions handled under deviation?", 15),
            Question("pr_monitoring_16", "pr_monitoring", "Are IPC frequencies defined scientifically?", 16),
            Question("pr_monitoring_17", "pr_monitoring", "Are IPC data integrated into release decisions?", 17),
            Question("pr_monitoring_18", "pr_monitoring", "Are IPC failures linked to CAPA if recurring?", 18),
            Question("pr_monitoring_19", "pr_monitoring", "Are IPC analysts trained and qualified?", 19),
            Question("pr_monitoring_20", "pr_monitoring", "Are IPC specifications harmonized with final specs?", 20),
            Question("pr_monitoring_21", "pr_monitoring", "Are IPC samples protected from contamination?", 21),
            Question("pr_monitoring_22", "pr_monitoring", "Are results compared with historical limits?", 22),
            Question("pr_monitoring_23", "pr_monitoring", "Are monitoring strategies updated periodically?", 23),
            Question("pr_monitoring_24", "pr_monitoring", "Are PAT alerts categorized by severity?", 24),
            Question("pr_monitoring_25", "pr_monitoring", "Are IPC records stored in validated systems?", 25),

            // Handling of Highly Potent & Sensitizing Drugs
            Question("pr_potent_drugs_1", "pr_potent_drugs", "Are OEL (Occupational Exposure Limits) defined for HPAPIs?", 1),
            Question("pr_potent_drugs_2", "pr_potent_drugs", "Are containment systems (isolators, RABS) validated?", 2),
            Question("pr_potent_drugs_3", "pr_potent_drugs", "Are PPE requirements defined based on risk?", 3),
            Question("pr_potent_drugs_4", "pr_potent_drugs", "Are  cleaning procedures validated to prevent cross-contamination?", 4),
            Question("pr_potent_drugs_5", "pr_potent_drugs", "Are dedicated equipment areas used where required?", 5),
            Question("pr_potent_drugs_6", "pr_potent_drugs", "Are transfer processes closed to minimize exposure?", 6),
            Question("pr_potent_drugs_7", "pr_potent_drugs", "Are airborne monitoring methods in place?", 7),
            Question("pr_potent_drugs_8", "pr_potent_drugs", "Are spill handling procedures documented and trained?", 8),
            Question("pr_potent_drugs_9", "pr_potent_drugs", "Are operator medical surveillance programs implemented?", 9),
            Question("pr_potent_drugs_10", "pr_potent_drugs", "Are production areas segregated physically?", 10),
            Question("pr_potent_drugs_11", "pr_potent_drugs", "Are waste materials handled as per hazardous waste procedures?", 11),
            Question("pr_potent_drugs_12", "pr_potent_drugs", "Are tablet presses and granulators fully sealed?", 12),
            Question("pr_potent_drugs_13", "pr_potent_drugs", "Are vacuum systems HEPA-filtered?", 13),
            Question("pr_potent_drugs_14", "pr_potent_drugs", "Are entry/exit airlocks validated?", 14),
            Question("pr_potent_drugs_15", "pr_potent_drugs", "Are charging operations closed or highly contained?", 15),
            Question("pr_potent_drugs_16", "pr_potent_drugs", "Are surfaces monitored for contamination?", 16),
            Question("pr_potent_drugs_17", "pr_potent_drugs", "Are product changeover procedures risk-based?", 17),
            Question("pr_potent_drugs_18", "pr_potent_drugs", "Are exposure containment failures escalated immediately?", 18),
            Question("pr_potent_drugs_19", "pr_potent_drugs", "Are operators trained and qualified specifically for HPAPI handling?", 19),
            Question("pr_potent_drugs_20", "pr_potent_drugs", "Are engineering controls periodically validated?", 20),
            Question("pr_potent_drugs_21", "pr_potent_drugs", "Are OEB (Occupational Exposure Bands) defined for all products?", 21),
            Question("pr_potent_drugs_22", "pr_potent_drugs", "Are health checks maintained confidentially?", 22),
            Question("pr_potent_drugs_23", "pr_potent_drugs", "Are cleaning limits more stringent for potent products?", 23),
            Question("pr_potent_drugs_24", "pr_potent_drugs", "Are HVAC systems designed for negative pressure where required?", 24),
            Question("pr_potent_drugs_25", "pr_potent_drugs", "Are simulant studies used to verify containment effectiveness?", 25),

            // Process Control
            Question("pr_process_control_1", "pr_process_control", "Are CPPs monitored in real time during manufacturing?", 1),
            Question("pr_process_control_2", "pr_process_control", "Are setpoints and ranges scientifically justified?", 2),
            Question("pr_process_control_3", "pr_process_control", "Are alarms defined with clear acceptance criteria?", 3),
            Question("pr_process_control_4", "pr_process_control", "Are automated controls validated?", 4),
            Question("pr_process_control_5", "pr_process_control", "Are manual overrides recorded and justified?", 5),
            Question("pr_process_control_6", "pr_process_control", "Are control charts used for monitoring trends?", 6),
            Question("pr_process_control_7", "pr_process_control", "Are mixing times documented and verified?", 7),
            Question("pr_process_control_8", "pr_process_control", "Are temperature/humidity conditions controlled?", 8),
            Question("pr_process_control_9", "pr_process_control", "Are critical control points documented in batch records?", 9),
            Question("pr_process_control_10", "pr_process_control", "Are equipment sensors calibrated regularly?", 10),
            Question("pr_process_control_11", "pr_process_control", "Are outlier process values investigated?", 11),
            Question("pr_process_control_12", "pr_process_control", "Are PLC programs access-controlled?", 12),
            Question("pr_process_control_13", "pr_process_control", "Are hold times monitored for intermediates?", 13),
            Question("pr_process_control_14", "pr_process_control", "Are deviations from control limits escalated promptly?", 14),
            Question("pr_process_control_15", "pr_process_control", "Are operators trained to understand CPPs?", 15),
            Question("pr_process_control_16", "pr_process_control", "Are automated audit trails reviewed?", 16),
            Question("pr_process_control_17", "pr_process_control", "Are process alarms tested periodically?", 17),
            Question("pr_process_control_18", "pr_process_control", "Are batch failures linked to process control deviations?", 18),
            Question("pr_process_control_19", "pr_process_control", "Are manual measurements periodically compared to automated readings?", 19),
            Question("pr_process_control_20", "pr_process_control", "Are data integrity controls in place for electronic systems?", 20),
            Question("pr_process_control_21", "pr_process_control", "Are control strategies aligned with process validation?", 21),
            Question("pr_process_control_22", "pr_process_control", "Are exceptions documented and risk assessed?", 22),
            Question("pr_process_control_23", "pr_process_control", "Are feedback controls evaluated for robustness?", 23),
            Question("pr_process_control_24", "pr_process_control", "Are upset conditions defined and tested?", 24),
            Question("pr_process_control_25", "pr_process_control", "Are process capabilities monitored continuously?", 25),
            Question("pr_process_control_1", "pr_process_control", "Are IPC parameters defined in master batch records?", 1),
            Question("pr_process_control_2", "pr_process_control", "Are IPC sampling tools cleaned and traceable?", 2),
            Question("pr_process_control_3", "pr_process_control", "Are IPC tests performed at controlled frequencies?", 3),
            Question("pr_process_control_4", "pr_process_control", "Are IPC results documented immediately?", 4),
            Question("pr_process_control_5", "pr_process_control", "Are IPC failures investigated?", 5),
            Question("pr_process_control_6", "pr_process_control", "Are portable IPC instruments calibrated?", 6),
            Question("pr_process_control_7", "pr_process_control", "Are IPC operators trained and evaluated?", 7),
            Question("pr_process_control_8", "pr_process_control", "Are environmental conditions recorded for IPC tests?", 8),
            Question("pr_process_control_9", "pr_process_control", "Are IPC samples stored under appropriate conditions?", 9),
            Question("pr_process_control_10", "pr_process_control", "Are moisture and particle size checks performed for granules?", 10),
            Question("pr_process_control_11", "pr_process_control", "Are compression force/IPQC parameters monitored?", 11),
            Question("pr_process_control_12", "pr_process_control", "Are coating parameters verified in real time?", 12),
            Question("pr_process_control_13", "pr_process_control", "Are IPC areas designed to avoid mix-ups?", 13),
            Question("pr_process_control_14", "pr_process_control", "Are IPC results reviewed before batch progression?", 14),
            Question("pr_process_control_15", "pr_process_control", "Are IPC forms controlled and versioned?", 15),
            Question("pr_process_control_16", "pr_process_control", "Are time gaps documented?", 16),
            Question("pr_process_control_17", "pr_process_control", "Are sample retain volumes justified?", 17),
            Question("pr_process_control_18", "pr_process_control", "Are IPC chambers (oven, desiccators)  labeled  and calibrated?", 18),
            Question("pr_process_control_19", "pr_process_control", "Are operators prevented from backdating entries?", 19),
            Question("pr_process_control_20", "pr_process_control", "Are IPC failures trended?", 20),
            Question("pr_process_control_21", "pr_process_control", "Are out-of-range values escalated?", 21),
            Question("pr_process_control_22", "pr_process_control", "Are  sampling plans scientifically justified?", 22),
            Question("pr_process_control_23", "pr_process_control", "Are samples taken from correct heights/locations?", 23),
            Question("pr_process_control_24", "pr_process_control", "Are IPC instruments stored securely?", 24),
            Question("pr_process_control_25", "pr_process_control", "Are IPC activities checked during audits?", 25),

            // Process Validation
            Question("pr_process_val_1", "pr_process_val", "Is there a validation master plan defining lifecycle  stages (PPQ -> Continued Verification) ?", 1),
            Question("pr_process_val_2", "pr_process_val", "Are critical process parameters (CPPs) and quality attributes (CQAs) scientifically justified?", 2),
            Question("pr_process_val_3", "pr_process_val", "Are PPQ runs performed under representative commercial conditions?", 3),
            Question("pr_process_val_4", "pr_process_val", "Are hold times validated and risk assessed?", 4),
            Question("pr_process_val_5", "pr_process_val", "Are scale-up batches included in validation planning?", 5),
            Question("pr_process_val_6", "pr_process_val", "Are worst-case conditions tested during PPQ?", 6),
            Question("pr_process_val_7", "pr_process_val", "Are blending/mixing uniformity studies performed?", 7),
            Question("pr_process_val_8", "pr_process_val", "Are  sampling plans statistically justified?", 8),
            Question("pr_process_val_9", "pr_process_val", "Are validation deviations handled under change control?", 9),
            Question("pr_process_val_10", "pr_process_val", "Are revalidation criteria defined?", 10),
            Question("pr_process_val_11", "pr_process_val", "Are equipment comparability studies included?", 11),
            Question("pr_process_val_12", "pr_process_val", "Are raw material variability studies included in validation?", 12),
            Question("pr_process_val_13", "pr_process_val", "Are process trends monitored throughout PPQ?", 13),
            Question("pr_process_val_14", "pr_process_val", "Are cleaning and sanitization steps considered in validation?", 14),
            Question("pr_process_val_15", "pr_process_val", "Are operator skill levels factored into validation?", 15),
            Question("pr_process_val_16", "pr_process_val", "Are yield ranges established and justified?", 16),
            Question("pr_process_val_17", "pr_process_val", "Are intermediate hold temperatures validated?", 17),
            Question("pr_process_val_18", "pr_process_val", "Are validation reports reviewed and approved by QA?", 18),
            Question("pr_process_val_19", "pr_process_val", "Are process capability indices (Cp/ Cpk ) calculated where applicable?", 19),
            Question("pr_process_val_20", "pr_process_val", "Are control charts used during PPQ to monitor variability?", 20),
            Question("pr_process_val_21", "pr_process_val", "Are alarms and interlocks tested during validation?", 21),
            Question("pr_process_val_22", "pr_process_val", "Are  sampling containers validated for compatibility?", 22),
            Question("pr_process_val_23", "pr_process_val", "Are site-transfer validations aligned with global standards?", 23),
            Question("pr_process_val_24", "pr_process_val", "Are validation documents traceable to URS and manufacturing instructions?", 24),
            Question("pr_process_val_25", "pr_process_val", "Are continuous verification metrics defined for ongoing monitoring?", 25),

            // Retain Samples
            Question("pr_retain_samples_1", "pr_retain_samples", "Are retain samples stored under  labeled  and controlled conditions?", 1),
            Question("pr_retain_samples_2", "pr_retain_samples", "Are retain quantities defined as per regulatory requirements?", 2),
            Question("pr_retain_samples_3", "pr_retain_samples", "Are storage rooms temperature- and humidity-controlled?", 3),
            Question("pr_retain_samples_4", "pr_retain_samples", "Are access controls implemented?", 4),
            Question("pr_retain_samples_5", "pr_retain_samples", "Are sample containers tamper-evident?", 5),
            Question("pr_retain_samples_6", "pr_retain_samples", "Are retains of all packaging components maintained?", 6),
            Question("pr_retain_samples_7", "pr_retain_samples", "Are retains inspected periodically for deterioration?", 7),
            Question("pr_retain_samples_8", "pr_retain_samples", "Are there procedures for destruction after retention period?", 8),
            Question("pr_retain_samples_9", "pr_retain_samples", "Are retain samples traceable to batch numbers?", 9),
            Question("pr_retain_samples_10", "pr_retain_samples", "Are cold-chain retains stored properly?", 10),
            Question("pr_retain_samples_11", "pr_retain_samples", "Are large-volume parenteral retains stored in proper orientation?", 11),
            Question("pr_retain_samples_12", "pr_retain_samples", "Are reconstituted-product retains stored appropriately?", 12),
            Question("pr_retain_samples_13", "pr_retain_samples", "Are retrieval logs maintained?", 13),
            Question("pr_retain_samples_14", "pr_retain_samples", "Are retain withdrawals justified?", 14),
            Question("pr_retain_samples_15", "pr_retain_samples", "Are retain areas included in self-inspections?", 15),
            Question("pr_retain_samples_16", "pr_retain_samples", "Are rejected batch retains segregated?", 16),
            Question("pr_retain_samples_17", "pr_retain_samples", "Are sample cross-contamination risks mitigated?", 17),
            Question("pr_retain_samples_18", "pr_retain_samples", "Are retains used in complaint investigations?", 18),
            Question("pr_retain_samples_19", "pr_retain_samples", "Are retain sample storage mapped for uniformity?", 19),
            Question("pr_retain_samples_20", "pr_retain_samples", "Are retains protected from light where needed?", 20),
            Question("pr_retain_samples_21", "pr_retain_samples", "Are labels legible throughout the retention period?", 21),
            Question("pr_retain_samples_22", "pr_retain_samples", "Are extreme temperature alarms monitored?", 22),
            Question("pr_retain_samples_23", "pr_retain_samples", "Are retains of serialized products controlled?", 23),
            Question("pr_retain_samples_24", "pr_retain_samples", "Are  bulk/API retains maintained?", 24),
            Question("pr_retain_samples_25", "pr_retain_samples", "Are retain storage tracking systems validated?", 25),

            // Material Traceability & Reconciliation
            Question("pr_traceability_1", "pr_traceability", "Are all raw materials traceable to supplier COAs and lot numbers?", 1),
            Question("pr_traceability_2", "pr_traceability", "Are dispensing records reconciled with usage?", 2),
            Question("pr_traceability_3", "pr_traceability", "Are barcode/RFID systems validated?", 3),
            Question("pr_traceability_4", "pr_traceability", "Are partial containers controlled to prevent mix-ups?", 4),
            Question("pr_traceability_5", "pr_traceability", "Are scrap quantities documented and justified?", 5),
            Question("pr_traceability_6", "pr_traceability", "Are yields trended for variability?", 6),
            Question("pr_traceability_7", "pr_traceability", "Are electronic material systems validated?", 7),
            Question("pr_traceability_8", "pr_traceability", "Are material movements recorded in real time?", 8),
            Question("pr_traceability_9", "pr_traceability", "Are quarantined materials clearly segregated?", 9),
            Question("pr_traceability_10", "pr_traceability", "Are rework/reprocess materials traceable?", 10),
            Question("pr_traceability_11", "pr_traceability", "Are rejected materials destroyed under control?", 11),
            Question("pr_traceability_12", "pr_traceability", "Are material balances reviewed during batch disposition?", 12),
            Question("pr_traceability_13", "pr_traceability", "Are packaging components reconciled batchwise?", 13),
            Question("pr_traceability_14", "pr_traceability", "Are  sampling plans linked to traceability?", 14),
            Question("pr_traceability_15", "pr_traceability", "Are  material mixing rules understood by operators?", 15),
            Question("pr_traceability_16", "pr_traceability", "Are staged materials  labeled  with expiry and status?", 16),
            Question("pr_traceability_17", "pr_traceability", "Are  ERP/MES systems access-controlled?", 17),
            Question("pr_traceability_18", "pr_traceability", "Are intermediate transfers documented?", 18),
            Question("pr_traceability_19", "pr_traceability", "Are warehouse-to-production material transfers recorded?", 19),
            Question("pr_traceability_20", "pr_traceability", "Are discrepancies investigated promptly?", 20),
            Question("pr_traceability_21", "pr_traceability", "Are serialized components reconciled?", 21),
            Question("pr_traceability_22", "pr_traceability", "Are allergen materials tracked separately?", 22),
            Question("pr_traceability_23", "pr_traceability", "Are solvent and bulk material traces maintained?", 23),
            Question("pr_traceability_24", "pr_traceability", "Are uncontrolled materials prohibited from production?", 24),
            Question("pr_traceability_25", "pr_traceability", "Are material reconciliation failures linked to CAPA?", 25)

        )
    }
    
    fun getQuestionsForSubDomain(subDomainId: String): List<Question> {
        return getAllQuestions().filter { it.domainId == subDomainId }
    }
}